Cellebrite DI (CLBT) 20-F 29 Mar 22 2021 FY Annual report (foreign) Financial data

Cover

Cover - shares	12 Months Ended
	Dec. 31, 2021	Mar. 11, 2022
Document Information [Line Items]
Document type	20-F
Document registration statement	false
Document annual report	true
Document period end date	Dec. 31, 2021
Current fiscal year end date	--12-31
Document transition report	false
Document shell company report	false
Entity file number	001-40772
Entity registrant name	Cellebrite DI Ltd.
Entity incorporation, state or country code	L3
Entity address, address line one	94 Shlomo Shmelzer Road
Entity address, city or town	Petah Tikva
Entity address, postal zip code	4970602
Entity address, country	IL
Entity common stock, shares outstanding (in shares)		188,540,480
Entity well-known seasoned issuer	No
Entity voluntary filers	No
Entity current reporting status	Yes
Entity interactive data current	Yes
Entity filer category	Non-accelerated Filer
Entity emerging growth company	true
Entity ex transition period	false
ICFR auditor attestation flag	false
Entity shell company	false
Amendment flag	false
Document fiscal year focus	2021
Document fiscal period focus	FY
Entity central index key	0001854587
Document accounting standard	U.S. GAAP
Ordinary shares, par value NIS 0.00001
Document Information [Line Items]
Title of 12(b) security	Ordinary shares, par value NIS 0.00001
Trading symbol	CLBT
Security exchange name	NASDAQ
Warrants to purchase ordinary shares
Document Information [Line Items]
Title of 12(b) security	Warrants to purchase ordinary shares
Trading symbol	CLBTW
Security exchange name	NASDAQ
Business contact
Document Information [Line Items]
Entity address, address line one	94 Shlomo Shmelzer Road
Entity address, city or town	Petah Tikva
Entity address, postal zip code	4970602
Entity address, country	IL
Contact personnel name	Avital Futterman
Country region	972
City area code	73
Local phone number	394-8000

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2021
Auditor Information [Abstract]
Auditor Name	KPMG
Auditor Location	Tel Aviv, Israel
Auditor Firm ID	1057

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands		Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents		$ 145,973	$ 128,709	[1]
Restricted cash		0	5,137	[1]
Short-term deposits		35,592	108,928	[1]
Trade receivables (net of allowance for doubtful accounts of $1,040 and $616 as of December 31, 2021 and December 31, 2020, respectively)		67,505	66,324	[1]
Prepaid expenses and other current assets		12,818	7,439	[1]
Contract acquisition costs		4,813	2,979	[1]
Inventories		6,511	4,754	[1]
Total current assets		273,212	324,270	[1]
Non-current assets
Other non-current assets		1,958	565	[1]
Deferred tax assets, net		9,800	7,372	[1]
Property and equipment, net		16,756	16,106	[1]
Intangible assets, net		11,228	6,611	[1]
Goodwill		26,829	9,463	[1]
Total non-current assets		66,571	40,117	[1]
Total assets		339,783	364,387	[1]
Current liabilities
Trade payables		9,546	4,727
Other accounts payable and accrued expenses		54,044	49,112
Deferred revenues		122,983	105,543
Total current liabilities		186,573	159,382
Long-term liabilities
Liability for employees’ severance benefits		375	366
Other long term liabilities		9,162	6,191
Deferred revenues		36,426	33,439
Restricted Sponsor Shares liability		44,712	0
Price Adjustment Shares liability		79,404	0
Derivative warrant liabilities		56,478	0
Total long-term liabilities		226,557	39,996
Total liabilities		413,130	199,378
Redeemable convertible preferred shares, NIS 0.00001 par value; 39,779,261 shares authorized, issued and outstanding as of December 31, 2020. Aggregate liquidation preference of $134,411, as of December 31, 2020**	[1]	0	101,205
Shareholders’ equity (deficiency)
Share capital, NIS 0.00001 par value; 3,454,112,863 shares authorized and 187,680,294 and 124,671,507 shares issued and outstanding as of December 31, 2021 and 2020, respectively**	[1],[2]	0	0
Additional paid-in capital		(153,072)	34,226
Treasury stock, NIS 0.00001 par value; 43,540 ordinary shares**		(85)	(85)
Accumulated other comprehensive income		1,372	1,321
Retained earnings		78,438	28,342
Total Shareholders’ equity (deficiency)		(73,347)	63,804
Total liabilities, redeemable convertible preferred shares and shareholders’ equity		$ 339,783	$ 364,387
Redeemable convertible preferred shares authorized (in shares)	[1]		39,779,261
[1]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 12, Shareholders’ Equity, for details .
[2]	Less than US$ 1.

Consolidated Balance Sheets - P

Consolidated Balance Sheets - Parenthetical $ in Thousands		Dec. 31, 2021USD ($)shares	Dec. 31, 2020USD ($)shares		Dec. 31, 2020₪ / shares
Statement of Financial Position [Abstract]
Trade receivable, allowance for credit loss | $		$ 1,040	$ 616
Redeemable convertible preferred shares, par value per share (in NIS per share) | ₪ / shares	[1]				₪ 0.00001
Redeemable convertible preferred shares authorized (in shares)	[1]		39,779,261
Redeemable convertible preferred shares issued (in shares)	[1]		39,779,261
Redeemable convertible preferred shares outstanding (in shares)		0	39,779,261	[1]
Redeemable convertible preferred shares, aggregate liquidation preference | $	[1]		$ 134,411
Common stock par value per share (in NIS per share) | (per share)					₪ 0.00001
Common stock, shares authorized (in shares)		3,454,112,863	3,454,112,863
Common stock, shares issued (in shares)		187,680,294	187,680,294
Common stock shares outstanding (in shares)		124,671,507	124,671,507
Treasury stock (in shares)		43,540	43,540
[1]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 12, Shareholders’ Equity, for details .

Consolidated Statement of Opera

Consolidated Statement of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenue:
Total revenue	$ 246,246	$ 194,913	$ 171,854
Cost of revenue:
Total cost of revenue	42,557	37,879	35,823
Gross profit	203,689	157,034	136,031
Operating expenses:
Sales and marketing	76,389	61,305	61,610
Research and development	65,541	54,377	46,573
General and administrative	47,937	32,134	29,368
Total operating expenses	189,867	147,816	137,551
Operating income (loss)	13,822	9,218	(1,520)
Financial income, net	68,483	2,179	2,935
Income before income tax expense	82,305	11,397	1,415
Income tax expense	10,909	5,616	3,291
Net income (loss)	71,396	5,781	(1,876)
Net income (loss) per share:
Basic net income (loss) per share attributable to ordinary shareholders	70,433	(9,344)	(10,039)
Diluted net income (loss) per share attributable to ordinary shareholders	$ 70,433	$ (9,344)	$ (10,039)
Basic net income (loss) per ordinary share (in USD per share)	$ 0.49	$ (0.08)	$ (0.08)
Diluted net income (loss) per share (in USD per share)	$ 0.44	$ (0.08)	$ (0.08)
Weighted average number of ordinary shares used in computing basic net income (loss) per share (in shares)	144,002,394	123,696,624	121,560,817
Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in shares)	161,538,579	123,696,624	121,560,817
Other comprehensive income (loss)
Unrealized gain (loss) on hedging transactions, net of taxes of $129 and $165 for the year ended December 31, 2021 and 2020 respectively	$ (944)
Unrealized gain (loss) on hedging transactions, net of taxes of $129 and $165 for the year ended December 31, 2021 and 2020 respectively		$ 1,212	$ 620
Foreign currency translation adjustments	995	(695)	(25)
Total other comprehensive income, net of tax	51	517	595
Total comprehensive income (loss)	71,447	6,298	(1,281)
Subscription services
Revenue:
Total revenue	120,889	100,614	81,505
Cost of revenue:
Total cost of revenue	9,369	8,795	6,585
Term-license
Revenue:
Total revenue	62,428	29,131	5,142
Cost of revenue:
Total cost of revenue	2,299	1,709	189
Perpetual license and other
Revenue:
Total revenue	34,169	42,136	59,175
Cost of revenue:
Total cost of revenue	9,817	9,370	10,049
Professional services
Revenue:
Total revenue	28,760	23,032	26,032
Cost of revenue:
Total cost of revenue	$ 21,072	$ 18,005	$ 19,000

Statements of Changes in Shareh

Statements of Changes in Shareholders' Equity (Deficiency) - USD ($)		Total	Cumulative effect, period of adoption, adjustment	[2]	Cumulative effect, period of adoption, adjusted balance	Ordinary shares		Ordinary sharesCumulative effect, period of adoption, adjusted balance		Additional paid-in capital	Additional paid-in capitalCumulative effect, period of adoption, adjusted balance	Treasury stock	Treasury stockCumulative effect, period of adoption, adjusted balance	Comprehensive income	Comprehensive incomeCumulative effect, period of adoption, adjusted balance	Retained earnings	Retained earningsCumulative effect, period of adoption, adjustment	[2]	Retained earningsCumulative effect, period of adoption, adjusted balance
Accounting Standards Update [Extensible Enumeration]		Accounting Standards Update 2014-09 [Member]
Temporary equity, beginning balance (in shares) at Dec. 31, 2018		0
Temporary equity, beginning balance at Dec. 31, 2018		$ 0
Redeemable convertible preferred shares
Issuance of redeemable convertible preferred shares (in shares)		39,779,261
Issuance of redeemable convertible preferred shares		$ 101,205,000
Temporary equity, ending balance (in shares) at Dec. 31, 2019		39,779,261
Temporary equity, ending balance at Dec. 31, 2019		$ 101,205,000
Beginning balance (in shares) at Dec. 31, 2018	[1]					119,818,040		119,818,040
Beginning balance at Dec. 31, 2018		69,217,000	$ 3,800,000		$ 73,017,000	$ 0	[3]	$ 0	[3]	$ 12,563,000	$ 12,563,000	$ (23,898,000)	$ (23,898,000)	$ 209,000	$ 209,000	$ 80,343,000	$ 3,800,000		$ 84,143,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(1,876,000)														(1,876,000)
Other comprehensive income (loss)
Foreign currency translation adjustments		(25,000)												(25,000)
Unrealized gain on hedging transactions, net		620,000												620,000
Stock based compensation		12,759,000								12,759,000
Exercise of shares option and vested RSUs (in shares)	[1]					3,664,884
Exercise of shares option and vested RSUs		141,000								141,000
Dividend paid		$ (25,000,000)														(25,000,000)
Repurchase of ordinary shares (in shares)		(295,000)				(283,045)	[1]
Repurchase of ordinary shares		$ (808,000)										(808,000)
Cancellation of ordinary shares		0										24,706,000				(24,706,000)
Ending balance (in shares) at Dec. 31, 2019	[1]					123,199,879
Ending balance at Dec. 31, 2019		$ 58,828,000				$ 0	[3]			25,463,000		0		804,000		32,561,000
Temporary equity, ending balance (in shares) at Dec. 31, 2020	[4]	39,779,261
Temporary equity, ending balance at Dec. 31, 2020	[4]	$ 101,205,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		5,781,000														5,781,000
Other comprehensive income (loss)
Foreign currency translation adjustments		(695,000)												(695,000)
Unrealized gain on hedging transactions, net		1,212,000												1,212,000
Stock based compensation		7,271,000								7,271,000
Exercise of shares option and vested RSUs (in shares)	[1]					1,513,404
Exercise of shares option and vested RSUs		1,492,000								1,492,000
Dividend paid		$ (10,000,000)														(10,000,000)
Repurchase of ordinary shares (in shares)		(43,540)				(41,776)	[1]
Repurchase of ordinary shares		$ (85,000)										(85,000)
Ending balance (in shares) at Dec. 31, 2020		124,671,507				124,671,507	[1]
Ending balance at Dec. 31, 2020		$ 63,804,000				$ 0	[3]			34,226,000		(85,000)		1,321,000		28,342,000
Redeemable convertible preferred shares
Conversion of preferred shares (in shares)		(39,779,261)
Conversion of preferred shares		$ (101,205,000)
Temporary equity, ending balance (in shares) at Dec. 31, 2021		0
Temporary equity, ending balance at Dec. 31, 2021	[4]	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		71,396,000														71,396,000
Other comprehensive income (loss)
Foreign currency translation adjustments		995,000												995,000
Unrealized gain on hedging transactions, net		(944,000)												(944,000)
Recapitalization transaction with TWC (in shares)	[1]					20,424,699
Recapitalization transaction with TWC		(213,722,000)								(213,722,000)
Issuance costs		(4,866,000)								(4,866,000)
Stock based compensation		6,480,000								6,480,000
Exercise of shares option and vested RSUs (in shares)	[1]					2,804,827
Exercise of shares option and vested RSUs		2,305,000								2,305,000
Conversion of preferred shares (in shares)	[1]					39,779,261
Conversion of preferred shares		101,205,000								101,205,000
Dividend paid		$ (100,000,000)								(78,700,000)						(21,300,000)
Ending balance (in shares) at Dec. 31, 2021		124,671,507				187,680,294	[1]
Ending balance at Dec. 31, 2021		$ (73,347,000)				$ 0				$ (153,072,000)		$ (85,000)		$ 1,372,000		$ 78,438,000
[1]	Less than US$ 1.
[2]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 12, Shareholders’ Equity, for details.
[3]	Less than US$ 1.
[4]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 12, Shareholders’ Equity, for details .

Statements of Changes in Shar_2

Statements of Changes in Shareholders' Equity (Deficiency) (Parenthetical)	Aug. 30, 2021
Statement of Stockholders' Equity [Abstract]
Reverse stock split, conversion ratio	0.9595

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net income (loss)	$ 71,396	$ 5,781	$ (1,876)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock based compensation	6,480	7,271	12,759
Depreciation and Amortization	7,007	5,879	4,079
Increase in deferred income taxes	(1,638)	(2,818)	(1,667)
Other	0	689	0
Revaluation of derivative warrants	(11,967)	0	0
Revaluation of Restricted Sponsor Shares and Price Adjustment Shares liabilities	(55,906)	0	0
Increase (decrease) in liability for employees' severance benefits	10	(63)	131
Increase in trade receivables	(1,958)	(19,731)	(12,220)
Increase in deferred revenues	21,804	47,738	15,841
Decrease (increase) in prepaid expenses and other current assets	(8,304)	335	(3,141)
Increase in other non-current assets	(1,394)	(339)	(27)
Decrease (increase) in inventories	(1,798)	(693)	794
Increase (decrease) in trade payables	4,239	(1,433)	974
Increase (decrease) in other accounts payables and accrued expenses	5,107	22,449	(158)
Increase in other long-term liabilities	2,974	1,445	644
Net cash provided by operating activities	36,052	66,510	16,133
Cash flows from investing activities:
Purchases of property and equipment	(5,111)	(6,181)	(6,209)
Payment related to business combination, net of cash acquired	(20,000)	(15,046)	0
Purchase of intangible asset	3,000	0	0
Short term deposits, net	73,337	14,778	(40,513)
Net cash provided by (used in) investing activities	45,226	(6,449)	(46,722)
Cash flows from financing activities:
Repurchase of common stock	0	(85)	(808)
Proceeds from exercise of shares	2,305	1,492	141
Proceeds from issuance of Redeemable convertible preferred shares, net of issuance costs	0	0	101,205
Payment of dividend	(100,000)	(10,000)	(25,000)
Proceeds from Recapitalization transaction, net	29,298	0	0
Net cash provided by (used in) financing activities	(68,397)	(8,593)	75,538
Net increase in cash, cash equivalents and restricted cash	12,881	51,468	44,949
Net effect of currency translation on cash, cash equivalents and restricted cash	(754)	695	(67)
Cash, cash equivalents and restricted cash at beginning of year	133,846	81,683	36,801
Cash and cash equivalents and restricted cash at end of year	145,973	133,846	81,683
Supplemental disclosure of cash flow information:
Income taxes paid, net of refund	8,157	2,911	3,000
Supplemental disclosure of Non-cash investment activities:
Purchase of property and equipment	$ 814	$ 172	$ 263

Consolidated Statement of Ope_2

Consolidated Statement of Operations (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Unrealized gain (loss) on hedging transactions, tax	$ 129
Unrealized gain (loss) on hedging transactions, tax		$ 165

General

General	12 Months Ended
	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
General	Note 1. General a. Cellebrite DI Ltd. (the “Company”), an Israeli company, was incorporated on April 13, 1999 as a private company, and began its operations in July 1999. The Company and its wholly owned subsidiaries are engaged in the development, manufacturing, marketing and selling of software and related hardware devices which allow access, unify, generate and analyze defendable digital evidence to its law enforcement customers. The Company’s primary shareholder is SUNCORPORATION, a public Company traded in the Japanese market, that creates novel ideas based on original technologies. b. On February 28, 2020, the Company completed the acquisition of 100% of the shares of BlackBag Technologies Inc. (“BlackBag”), a US computer collection and review solutions company, for the total base consideration $33,362. See also Note 3A. c. On August 30, 2021, the Company merged with TWC Tech Holdings II Corp. (“TWC”). As a result of the merger as agreed in the Merger Agreement, TWC became a direct, wholly owned subsidiary of the Company. Consequently, Cellebrite’s shares and warrants became listed on The Nasdaq Capital Market under the symbols “CLBT” and “CLBTW”, respectively. See also Note 3B. The merger is accounted as a recapitalization, with no goodwill or other intangible assets recorded, in accordance with U.S. GAAP. Under this method of accounting, Cellebrite has been determined to be the accounting acquirer. d. On November 11, 2021, the Company completed the acquisition of Digital Clues LTD. (“DC”) carved out assets, for a total consideration of $20,000. DC is an open-source intelligence providing the ability to view any online information to collect, analyze, and produce actionable intelligence. See also Note 3C. e. In March 2020, the World Health Organization (”WHO”) declared the novel coronavirus COVID-19 ("COVID-19") a global pandemic. The pandemic adversely affected workforce, economies, and financial markets globally in 2020 and, until contained, is still expected to disrupt general business operations. The COVID-19 pandemic and the ongoing measures being taken by many governments around the world in response could in the future meaningfully impact our business, installations, trainings and general operations . It is not possible at this time to estimate the full impact that COVID-19 will have on the Company’s business, as the impact will depend future developments, which are highly uncertain and cannot be predicted. Actual results could differ from our estimates and judgments, and any such differences may be material to our financial statements.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2. Summary of Significant Accounting Policies A. Basis of presentation The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (US GAAP). The significant accounting policies followed in the preparation of the financial statements, applied on a consistent basis for all years presented in these financial statements. B. Functional Currency and Foreign Currency Translation A majority of the Company’s revenues are generated outside of Israel and are denominated in US dollars (“US$” or “dollars”). Substantial portion of materials and components cost, and marketing costs, are denominated in dollars or dollar-linked. Therefore, the Company’s management believes that the US dollars is the currency of the primary economic environment in which the Company operates. Thus, the functional currency and the reporting currency of the Company is the US dollar. Transactions in foreign currency are translated into dollars in accordance with the principles set forth in ASC Subtopic 830-20, Foreign Currency Transaction. Monetary assets and liabilities denominated in foreign currencies of the reporting date are translated to the functional currency at the closing rate at the end of the reporting period. Non-monetary assets and liabilities denominated in foreign currency are translated using the exchange rate at the date of the transaction. The effect of the translating into dollars has been included in the consolidated statements of shareholders’ equity and comprehensive income (loss) as a foreign currency translation adjustment. Gains and losses from remeasurement assets and liabilities denominated in currencies other than the respective functional currencies are included in the consolidated statements of operations. C. Use of estimates The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods and accompanying notes. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include, but are not limited to, the allocation of transaction price among various performance obligation, the fair value of acquired intangible assets and goodwill, share-based compensation, unrecognized tax benefits, fair value measurement of restricted sponsor shares liability, price adjustment shares liability and derivative warrant liabilities. D. Principles of consolidation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances were eliminated in consolidation. E. Cash and cash equivalents and restricted cash The Company considers all highly liquid instruments with a maturity of three months or less at the date of purchase to be cash equivalents. Restricted cash consists of funds that are contractually restricted as to usage or withdrawal mainly due to a contractual agreement with an investor. The Company has presented restricted cash separately from cash and cash equivalents in the consolidated balance sheets. F. Trade Receivable Trade receivables are recorded at the invoiced amount net of allowance for doubtful accounts. The allowance for doubtful accounts is based on the Company’s assessment of in the collectability of accounts. The Company regularly reviews the adequacy of the allowance for doubtful accounts based on combination of factors, including as assessment of the current customer’s aging report, the nature and size of the customer, the financial condition of the customer and the amount of any receivables in dispute. Trade receivables deemed uncollectible are charged off against the allowance for doubtful accounts after all means of collection have been exhausted and the potential for recovery is considered remote. G. Inventories Inventories are stated at the lower of cost or net realizable value. Cost is determined by the “weighted moving average” method. Inventory write-downs are provided to cover technological obsolescence, excess inventories and discontinued products. Inventory write-down is measured as the difference between the cost of the inventory and market based upon assumptions about future demand, and is charged to cost of revenues. At the point of the loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis. H. Property and equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates: % Computers and software 12.5 – 33 Manufacturing equipment 7 Office furniture and equipment 7– 15 Leasehold improvements * *Over the shorter of the expected lease term or estimated useful lives. I. Impairment of long-lived assets Long-lived assets, such as property and equipment, and identifiable intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable in accordance with ASC 360, Accounting for the impairment of Long-Lived Assets. If events of changes in the circumstances indicate that a long-lived asset or asset group value may not be recoverable, the Company compares aggregate undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If these cash flows are less than the carrying value, an impairment is recognized for the difference between the carrying value and the estimated fair value. Fair value is determined through discounted cash flow models and third-party independent appraisals, as considered necessary. The measurement of impairment requires management to estimate future cash flows and the fair value of long-lived assets. The evaluation is performed at the lowest levels for which there are identifiable, independent cash flows. During the year ended December 31, 2021, 2020 and 2019, no impairment losses have been identified. J. Revenue recognition The Company’s revenues are comprised of four main categories: (a) subscription revenues, including support services (updates, upgrades and technical support) on term-based licenses and perpetual licenses; (b) subscription revenues also from sales of term-based licenses; (c) perpetual licenses (and others); and (d) professional services. The Company recognizes revenue pursuant to the five-step framework contained in ASC 606, Revenue from Contracts with Customers: (i) identify the contract with a client; (ii) identify the performance obligations in the contract, including whether they are distinct in the context of the contract; (iii) determine the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligations The Company sells its products to its customers either directly or indirectly through distribution channels all of whom are considered end users. In accordance with ASC 606, revenue is recognized when a customer obtains control of promised goods or services are delivered. The amount of revenue recognized reflects the consideration that the Company expects to receive in exchange for these goods or services. The Company determines that it has a contract with a customer when each party’s rights regarding the products or services to be transferred can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation. Performance obligations promised in a contract are identified based on the products and services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the products or services either on their own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the products and services is separately identifiable from other promises in the contract. The Company’s software licenses either provide its customers a perpetual right to use its software or the right to use its software for only a fixed term, in most cases between a one- and three-year time frame. The Company concluded that the software license is distinct as the customer can benefit from the software on its own. Support revenue is derived from providing technical customer support services, unspecified software updates and upgrades to customers several times a year, on a when-and-if-available basis. Performance obligations related to software maintenance services generally have a consistent continuous pattern of transfer to a customer during the contract period. Professional services revenues primarily consist of training and other professional services. Each of these performance obligations provide benefit to the customer on a standalone basis and are distinct in the context of the contract. The transaction price is determined based on the consideration to which the Company expects to be entitled in exchange for transferring products or delivery of services to the customer. Payment terms generally are net 30 days. The Company applied the practical expedient in ASC 606 and did not evaluate payment terms of one year or less for the existence of a significant financing component. Revenue is recognized net of any taxes collected from customers which are subsequently remitted to governmental entities (e.g., sales tax and other indirect taxes). The Company does not offer right of return to its contracts. If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. For contracts that contain multiple performance obligations, the Company allocates the transaction price to each performance obligation based on the relative standalone selling price (“SSP”) for each performance obligation. The Company uses judgment in determining the SSP for its products and services. The Company typically assesses the SSP for its products and services on a periodic basis or when facts and circumstances change. To determine SSP, the Company maximizes the use of observable standalone sales and observable data, where available. In instances where performance obligations do not have observable standalone sales, the Company utilizes available information that may include the entity specific factors such as assessment of historical data of bundled sales of software licenses with other promised goods and services, and pricing strategies to estimate the price the Company would charge if the products and services were sold separately. The Company satisfies performance obligations either over time or at a point in time depending on the nature of the underlying promise. Revenue is recognized at the time the related performance obligation is satisfied by transferring a promised good or service to a customer. Revenues related to the license for proprietary software are recognized when the control over the license is provided to the customer and the license term begins. Revenue related to software update and upgrades are recognized ratably over the service period. Revenues related to other professional services are generally recognized over time and in certain cases at point in time upon satisfaction of the performance obligation. Service revenues are included in the Company’s consolidated statements of income as service revenues. Disaggregation of Revenues The following table provides information about disaggregated revenue by geographical areas Year Ended December 31, 2021 2020 2019 EMEA $ 88,441 $ 65,807 $ 55,911 America 126,929 100,835 89,514 APAC 30,876 28,271 26,429 Total $ 246,246 $ 194,913 $ 171,854 Contract Balances The following table provides information about accounts receivable, contract assets, and contract liabilities from contracts with customers: December 31, 2021 December 31, 2020 Contract assets $ 8,567 $ 3,967 Contract liabilities, current 122,983 105,543 Contract liabilities, non-current $ 36,426 $ 33,439 Contract assets consist of unbilled accounts receivable, which occur when a right to consideration for the Company’s performance under the customer contract occurs before invoicing to the customer. The increase in contract balances is consistent with the increase in the overall operation of the Company. Contract liabilities consist of deferred revenue. Revenue is deferred when the Company invoices in advance of performance under a contract. The current portion of the deferred revenue balance is recognized as revenue during the 12-month period after the balance sheet date. The non current portion of the deferred revenue balance is recognized as revenue following the 12-month period after the balance sheet date. Of the $138,982 and $159,409 of deferred revenue as of December 31, 2020 and December 31, 2019, respectively, the Company recognized $97,823 and $61,964 as revenue during the year ended December 31, 2021 and 2020, respectively. Remaining Performance Obligations The Company’s remaining performance obligations are comprised of product and services revenue not yet delivered. As of December 31, 2021 and December 31, 2020, the aggregate amount of the transaction price allocated to remaining performance obligations was $231,666 and $172,885 respectively, which consists of both billed consideration in the amount of $159,409 and $138,982 respectively, and unbilled consideration in the amount of $72,257 and $33,903 respectively, that the Company expects to recognize as revenue. As of December 31, 2021, the Company expects to recognize 61% of its remaining performance obligations as revenue in the year ended December 31, 2022 and the remainder thereafter. Contract acquisition costs The Company capitalizes sales commissions and associated payroll taxes paid to sales personnel that are incremental to obtaining customer contracts. These costs are recorded as deferred contract acquisition costs on the consolidated balance sheets. The Company determines whether costs should be deferred based on its sales compensation plans and if the commissions are incremental and would not have occurred absent the customer contract. Sales commissions for the renewal of a contract are considered commensurate with the sales commissions paid for the acquisition of the initial contract given no substantive difference in commission rates in proportion to their respective contract values. Sales commissions paid upon the initial acquisition and for the renewal of a contract are amortized over the contractual term of the initial contract or the renewal. Amortization of sales commissions are consistent with the pattern of revenue recognition of each performance obligation and are included in sales and marketing expense in the consolidated statements of operations. The Company periodically reviews these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. No impairment losses of capitalizes sales commissions were recorded during the periods presented. Commission expenses for the year ended December 31, 2021, 2020 and 2019 were $10,700, $8,400 and $6,800 respectively. K. Research and development costs Research and development costs are expensed as incurred. As defined by ASC Subtopic 985-20 “Accounting for the Cost of Computer Software to be Sold, Leased or Otherwise Marketed”, costs associated with the development of computer software which are incurred subsequent to the establishment of technological feasibility, are capitalized thereafter until the product is available for general release to customers. Costs incurred by the Company between completion of the development and the point at which the product is ready for general release, have been insignificant. Therefore, all research and development costs are expensed as incurred. L. Product warranties The Company provides a one-year warranty on most of its products. Estimated future warranty costs are accrued and charged to cost of goods sold in the period that the related revenue is recognized. These estimates are derived from historical data and trends of product reliability and costs of repairing and replacing defective products. M. Advertising expenses Advertising expenses are charged to expense as incurred. Advertising expenses for the years 2021, 2020 and 2019 were $5,274, $4,098 and $5,315 respectively. N. Income taxes The Company accounts for income taxes in accordance with ASC 740, “Income Taxes”. ASC 740 prescribes the use of the liability method whereby deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period of enactment. A valuation allowance is provided, if necessary, to reduce deferred tax assets to the amount that is more likely than not to be realized. Deferred tax assets and deferred tax liabilities are presented under long-term assets. The Company implements a two-step approach to recognize and measure uncertainty in income taxes. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is greater than 50 percent (cumulative basis) likely to be realized upon settlement. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company classifies interest and penalties related to unrecognized tax benefits as part of income taxes. O. Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718 (ASC718). ASC 718 requires that all stock-based compensation be recognized as an expense in the financial statements and that such cost be measured at the fair value of the award. The Company recognizes compensation expense on a straight line method. The fair value of the shares of ordinary shares underlying the stock options has historically been determined by the Company’s board of directors as there was no public market for the underlying ordinary shares. The Company’s board of directors determines the fair value of the Company’s ordinary shares by considering a number of objective and subjective factors including: contemporaneous third-party valuations of its ordinary shares, the valuation of comparable companies, sales of the Company’s ordinary and redeemable convertible preferred shares to outside investors in arms-length transactions, the Company’s operating and financial performance, the lack of marketability, and general and industry specific economic outlook, amongst other factors. For all share options granted, the Company calculated the expected term using the simplified method for “plain vanilla” stock option awards. The risk-free interest rate is based on the yield available on U.S. Treasury zero-coupon issues similar in duration to the expected term of the stock-based award. The Company calculates the fair value of share options on the date of grant using the Black-Scholes option-pricing model and the expense is recognized over the requisite service period for awards expected to vest using the straight line method. The Company utilized a dividend yield of 0-5%. Stock based compensation costs have been included in income from operations. P. Fair value measurements The Company accounts for fair value in accordance with ASC 820, “Fair Value Measurements and Disclosures”. Fair value is defined under ASC 820 as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows: • Level 1: Quoted prices in active markets for identical assets or liabilities. • Level 2: Inputs other than Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. • Level 3: Unobservable inputs for the asset or liability used to measure fair value that are supported by little or no market activity and that re significant to the fair value of the asset or liability at measurement date. The first two levels in the hierarchy are considered observable inputs and the last is considered unobservable. The carrying value of accounts receivable and payables and the Company’s cash and cash equivalents, restricted cash and short-term investments, approximates fair value due to the short time to expected payment or receipt of cash. Derivative warrant liabilities Upon the closing of the transaction, 20,000,000 public warrants and 9,666,667 private warrants, that were both issued by TWC prior to the transaction, were outstanding to purchase the Company’s ordinary shares. Each warrant entitles the holder to purchase one Company Ordinary Share at a price of $11.50 per share, subject to adjustments. The warrants are exercisable at any time commencing 30 days after the completion of the transaction and expire five years after the Closing Date or earlier upon redemption or liquidation. The Company may redeem the outstanding public warrants in whole and not in part at a price of $0.01 per warrant at any time after they become exercisable, provided that the last sale price of the Company ordinary shares equals or exceeds $18 per share, subject to adjustments, for any 20-trading days within a 30-trading day period ending three business days prior to the date on which the Company sends the notice of redemption to the warrant holders. The private warrants have similar terms as the public warrants, except that the private warrants may be exercised for cash or on a cashless basis at the holder’s option and the private warrants will not be redeemed by the Company as long as they are held by the initial purchasers or their permitted transferees, but once they are transferred, they have the same rights as the public warrants. As the private warrants include provisions that provide for potential changes to the settlement amounts that are dependent on the characteristics of the holder of the warrant, under ASC Section 815-40, those warrants are not indexed to the Company’s ordinary shares in the manner contemplated by that Section, so long as they are held by the initial purchasers or their permitted transferees. The Public Warrants may be exercised with a different mechanism, depends on whether the Company maintain an effective registration statement or not. Since, among other things, the fact whether the Company maintains an effective registration statement effect the settlement provision of the Public Warrants (i.e., the cap is applicable depends on whether the registration statement is effective or not), is not an input into the pricing of fixed for fixed option model on equity shares, the Public Warrants are precluded from being indexed to the Company's own stock and should be classified as a liability. Therefore, the public and private warrants were classified as a liability measured at fair value pursuant to ASC 480 “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. Public Warrants Private Placement Warrants Total Derivative Warrant liability Warrant liability assumed from the Business Combination $ 34,400 $ 34,045 $ 68,445 Change in fair value of warrant liability 800 (12,767) (11,967) Balance, December 31, 2021 $ 35,200 $ 21,278 $ 56,478 The estimated fair value of the private placement warrant derivative liabilities is determined using Level 3 inputs. Inherent in a Black-Scholes valuation model are assumptions related to expected stock-price volatility, expiration, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expiration of the warrants. The dividend yield is based on the historical rate, which the Company anticipates will remain at 0-5%. The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: As of December 31, 2021 Number of private placement warrants 9,666,667 Exercise price $11.5 Share price $8.02 Expiration term (in years) 4.66 Volatility 44.8% Risk-free Rate 1.22% Dividend yield 0% - 5% Restricted sponsor shares liability and Price adjustment shares 7,500,000 Ordinary Shares issued to the Sponsor, out of a total of 13,500,000 shares, are Restricted Shares and will vest in 3 tranches of 3,000,000, 3,000,000 and 1,500,000, upon achievement of the of the triggering events (as defined in the business combination agreement); if at any time during the Price Adjustment Period the price of Cellebrite Ordinary Shares will be greater than or equal to $12.50, $15.00 and $30.00, respectively, over any twenty trading days within any thirty trading day period. In the event of a post-Closing change of control transaction involving the Company, any Restricted Shares not previously vested will vest and will be entitled to participate in the change of control transaction. The probability of such event was considered by the Company. Upon the expiration of the Price Adjustment Period (a period of seven years), any unvested Cellebrite Shares that have not vested as of such time will be forfeited. Cellebrite security holders shall be entitled to vote their unvested Restricted Shares and receive dividends and other distribution, and to have all other economic rights, in each case, with respect to such Restricted Shares while they remain unvested. Holders of the Company’s Ordinary Shares and vested Restricted Share Units, in each case as of immediately prior to the effective time, are eligible to receive up to 15,000,000 Ordinary Shares that will vest in 3 tranches of 5,000,000 upon achievement of the of the triggering events (if at any time during the Price Adjustment Period the price of Cellebrite Ordinary Shares will be greater than or equal to $12.50, $15.00 and $30.00, respectively, over any twenty trading days within any thirty trading day period.) or upon a Change of Control (as defined in business combination agreement) before the five Following the Merger, the Company issued equity and debt instrument. Transaction expenses were allocated on a relative fair value basis. Restricted sponsor shares Price adjustment shares Total Earn out shares assumed from the Business Combination $ 62,347 $ 117,675 $ 180,022 Change in fair value of warrant liability (17,635) (38,271) (55,906) Balance, December 31, 2021 $ 44,712 $ 79,404 $ 124,116 Q. Derivative instruments The Company has instituted a foreign currency cash flow hedging program using foreign currency forward contracts (“derivative instruments”) in order to hedge the exposure to variability in expected future cash flows resulting from changes in related foreign currency exchange rates. The Company hedges portions of its forecasted expenses denominated in NIS. These transactions are designated as cash flow hedges, as defined under ASC 815, “Derivatives and Hedging” . As of December 31, 2021 and 2020, the amount recorded in accumulated other comprehensive income from the Company’s currency forward, net of tax, was $577 and $1,521, respectively. As of December 31, 2021, the notional amounts of foreign exchange forward contracts into which the Company entered were $15,623. The foreign exchange forward contracts will expire by May 13, 2022. The fair value of derivative instruments assets balances as of December 31, 2021 and 2020, totaled $964 and $2,016, respectively. R. Goodwill Goodwill represents the excess of the purchase price in a business combination over the fair value of the net tangible and intangible assets acquired. Under ASC 350, “Intangible — Goodwill and Other”, goodwill is not amortized, but rather is subject to an annual impairment test. ASC 350 requires goodwill to be tested for impairment at the reporting unit level at least annually, the fourth quarter, or between annual tests in certain circumstances, and written down when impaired. Goodwill is tested for impairment by comparing the fair value of the reporting unit with its carrying value. The Company has determined that it has one operating segment and one reporting unit. ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If it does result in a more likely than not indication of impairment, the two-step impairment test is performed. Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the first step of the goodwill impairment test. There were no impairment charges to goodwill during the period presented. S. Intangible asset s Intangible assets are amortized over their estimated useful lives using the straight-line method, at the following annual period ranges: Years Core technology 5- 7 Trade name 4 Customer relationship 10 Each period the Company evaluates the estimated remaining useful lives of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization. T. Business combination The Company applies the provisions of ASC 805, “Business Combination” and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, the Company estimated the future expected cash flows from acquired core technology and acquired trade name from a market participant perspective, useful lives and discount rates. In addition, management makes significant estimates and assumptions, which are uncertain, but believed to be reasonable. Significant estimates in valuing certain intangible assets include, but are not limited to future expected cash flows from acquired technology and acquired trademarks from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Acquisition-related costs are recognized separately from the acquisition and are expensed as incurred. U. Concentrations of credit risk Financia

Business combination

Business combination	12 Months Ended
	Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]
Business combination	Note 3. Business combination a. Acquisition of BlackBag Technologies Inc.: On February 27, 2020, the Company completed the acquisition of 100% of the shares of BlackBag Technologies Inc. (“BlackBag”), a US computer collection and review solutions company, for a total consideration of $33,362. Out of the total consideration, $15,362 was paid in cash at the closing and additional $18,000 will be paid in three installments, $6,000 each year in the first, second and third anniversary of the closing. $13,000 out of the $18,000 are subject to the attainment of certain employee retention and are recognized over two years as payroll expenses and are not included within the total purchase price. Acquisition expenses were $1,848 during 2020 and consist of costs incurred to complete the acquisition and related integration charges. These charges were recorded in general and administrative expenses. Upon acquisition, BlackBag became a wholly owned subsidiary of the Company. The acquisition was accounted for as a business combination. The Company recorded trade name, core technology and goodwill in the amounts of $4,000, $3,900 and $9,463, respectively. The estimated useful life of the trade name and core technology are 4 years and 7 years, respectively. The Company recognized $1,289 and $1,546 amortization costs related to these intangible assets for the year ended December 31, 2021 and December 31, 2020, respectively. b. On April 8, 2021, the Company entered into a Business Combination Agreement and Plan of Merger (the “Merger Agreement”) with TWC Tech Holdings II Corp. (“TWC”), a public listed company in Nasdaq and Cupcake Merger Sub, Inc., a new wholly-owned subsidiary of Cellebrite (the “Merger Sub”) in the USA. TWC is a Special Purpose Acquisition Company (SPAC). On August 30, 2021, the Merger was consummated. Upon the terms and subject to the conditions of the Merger Agreement, at the Effective Time, Merger Sub merged with and into TWC, the separate corporate existence of Merger Sub ceased and TWC became the surviving corporation and a wholly-owned subsidiary of the Company (the “Merger”). TWC became a wholly-owned subsidiary of the Company and the security holders of TWC became security holders of the Company. On the date of Closing of the Merger (the “Closing”) and prior to the Merger becoming effective by acceptance of the Merger Certificate for filing by the Secretary of State of the State of Delaware, and prior to the Company’s Preferred Share conversion into Ordinary Shares as described below, an initial dividend of $21,300 (“Initial Dividend”) and an additional dividend of $78,700 (“Additional Dividend”) were paid to the holders of Company’s Ordinary Shares, Preferred Shares and vested restricted stock units (“RSU”) (all the “Company Shareholders”). Immediately after the payment of the Initial Dividend and the Additional Dividend and prior to the Effective Time each Company Preferred Share was automatically converted into Ordinary Share in accordance with the terms in Cellebrite’s Article of Association. Immediately following such conversion but prior to the Effective Time, the Company effected a reverse stock split of each Company Ordinary Share into such number of Company Ordinary Shares, which set the Ordinary Share value at $10 ( See also Note 12). Furthermore, Cellebrite issued TWC security holders the following securities at the Effective Time: each Public Share was converted into the right to receive one (1) Ordinary Share (the “Per Share Merger Consideration”). At the Effective Time each private warrant of TWC and each Public Warrant was converted into a warrant of Cellebrite, exercisable for the amount of Per Share Merger Consideration that the holder thereof would have received if such warrant had been exercisable and exercised immediately prior to the Business Combination. Additionally, each option and restricted stock unit of Cellebrite remain outstanding, subject to adjusted terms to reflect the effect of the Stock Split on Ordinary Shares. Concurrently with the execution of the Merger Agreement, certain accredited investors (the “PIPE Investors” and each, a “PIPE Investor”) entered into share purchase agreements (the “Share Purchase Agreements” and each, a “Share Purchase Agreement”) pursuant to which the PIPE Investors committed to purchase Ordinary Shares from certain Cellebrite shareholders at a purchase price of $10.00 per share in an aggregate number equal to 30,000,000 and an aggregate purchase price of $300,000 (the “PIPE Investments” and each, a “PIPE Investment”) on the closing date of August 30, 2021 (the “Closing Date”), which were converted into 30,000,000 Ordinary Shares upon the consummation of the Merger (the “PIPE Shares”). The PIPE Investment closed immediately prior to the Merger c. Acquisition of Digital Clues carved Out Assets : On November 11, 2021, the Company completed the acquisition of Digital Clues LTD. (“DC”) carved out assets, for a total consideration of $20,000 . DC is an open-source intelligence providing the ability to view any online information to collect, analyze, and produce actionable intelligence. The purchase price allocation for the acquisition has been determined as follows: Amount Net assets $ (890) Technology 3,347 Customer relationship 177 Goodwill 17,366 Total $ 20,000 Goodwill is primarily attributable to expected synergies arising from technology integration and expanded product availability to the Company’s existing and new customers. Goodwill is deductible for income tax purpose. The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition: Fair Value Useful Life US$ thousands In years Core technology 3,347 7 Customer relationship 177 10 Total identifiable intangible assets $ 3,524 The Company recorded amortization expenses of $67 for the year ended December 31, 2021. Additionally, the Company incurred transaction costs $267 during the year ended December 31, 2021, which were included in general and administrative expenses in the Consolidated Statements of Operations.

Intangible assets, net

Intangible assets, net	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible assets, net	Note 4. Intangible assets, net Definite-lived intangible assets: December 31, 2021 December 31, 2020 Original amounts: Core technology $ 10,411 $ 4,000 Trade name 3,900 3,900 Customer relationship 177 — 14,488 7,900 Accumulated amortization: Core technology 1,470 476 Trade name 1,788 813 Customer relationship 2 — 3,260 1,289 Intangible assets, net $ 11,228 $ 6,611 a. Amortization expense amounted to $1,971, $1,289 and $0 for the years ended December 31, 2021, 2020 and 2019, respectively. b. The expected future amortization expenses by year related to the intangible assets as of December 31, 2021 are as follows: 2022 $ 2,655 2023 2,655 2024 1,843 2025 1,680 2026 and thereafter 2,395 $ 11,228

Short-term deposits

Short-term deposits	12 Months Ended
	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Short-term deposits	Note 5. Short-term deposits Short-term deposits consist of short-term deposits and restricted deposits. Short-term deposits as of December 31, 2021 and ,2020 amounts to $35,592 and $108,928, respectively. The deposits carry interest rates in 2021 is between 0.1% – 1.55% (2020: 0.27% – 2.47%).

Prepaid expenses and other curr

Prepaid expenses and other current assets	12 Months Ended
	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid expenses and other current assets	Note 6. Prepaid expenses and other current assets December 31, 2021 December 31, 2020 Advances to suppliers $ 827 $ 163 Prepaid expenses 8,927 4,319 Government institutions 1,662 811 Other 1,402 2,146 $ 12,818 $ 7,439

Inventories

Inventories	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
Inventories	Note 7. Inventories December 31, 2021 December 31, 2020 Raw materials $ 4,742 $ 3,279 Finished goods 1,769 1,475 $ 6,511 $ 4,754

Property and equipment, net

Property and equipment, net	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Property and equipment, net	Note 8. Property and equipment, net December 31, 2021 December 31, 2020 Manufacturing equipment $ 526 $ 509 Furniture and equipment 8,294 6,898 Leasehold improvements 6,637 6,430 Computers and software 22,735 18,931 38,192 32,768 Less—accumulated depreciation (21,436) (16,662) $ 16,756 $ 16,106 Depreciation expenses were $5,036, $4,464 and $3,587 in the year ended December 31, 2021, 2020 and 2019, respectively.

Other accounts payable and accr

Other accounts payable and accrued expenses	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
Other accounts payable and accrued expenses	Note 9. Other accounts payable and accrued expenses December 31, 2021 December 31, 2020 Governmental institution $ 2,372 $ 2,192 Employees and related expenses 29,725 28,098 Income tax payable 8,235 6,610 Accrued expenses 12,800 11,037 Phantom option units liability — 538 Advances from customers 695 559 Other 217 78 $ 54,044 $ 49,112

Commitments

Commitments	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments	Note 11. Commitments The Company has rent agreements for its offices and plants, that are accounted for as operating leases. The latest period included in the agreements will end by February 28, 2031. Certain agreements have extension options. Future minimum lease commitments under non-cancellable operating leases as of December 31, 2021, are as follows: US$ thousands 2022 $ 4,890 2023 4,251 2024 5,417 2025 2,221 2026 and thereafter 1,722 $ 18,501

Liability for employees severan

Liability for employees severance benefits	12 Months Ended
	Dec. 31, 2021
Postemployment Benefits [Abstract]
Liability for employees severance benefits	Note 10. Liability for employees severance benefits a. Under Israeli law and labor agreements, the Company is required to make severance payments to retired or terminated employees and to employees leaving employment in certain other circumstances. The liability of the Company to pay severance pay to its employees is covered by the provision and by the payment of premiums for insurance policies. The Company makes payments into a general provident fund. The amounts deposited in the provident fund and the amounts paid for insurance policies in the names of the companies include accrued profits and may be withdrawn subject to restrictions determined by law. b. According to Section 14 to the Severance Pay Law (“Section 14”) in Israel the payment of monthly deposits by a company into recognized severance and pension funds or insurance policies releases it from any additional severance obligation to the employees that have entered into agreements with the company pursuant to such Section 14. Commencing from 2007, the Company has entered into agreements with a majority of its employees in order to implement Section 14. Therefore, beginning that date, the payment of monthly deposits by the Company into recognized severance and pension funds or insurance policies releases it from any additional severance obligation to those employees that have entered into such agreements and therefore the Company incurs no additional liability since that date with respect to such employees. Amounts accumulated in the pension funds or insurance policies pursuant to Section 14 are not supervised or administrated by the Company and therefore neither such amounts nor the corresponding accrual are reflected in the Company’s Consolidated Financial Statements. In addition, we pay severance benefits to our employees located elsewhere in accordance with local laws and practices of the countries in which they are employed and as a result have no accumulated liability. For the year ended December 31, 2021, 2020 and 2019 severance pay expenses amounted to $4,067, $3,340 and $3,476 respectively. c. The US Subsidiary has a defined contribution plan (the “Contribution Plan”) under the provisions of Section 401(k) of the Internal Revenue Code (the “Code”) which covers eligible U.S. employees as they are defined in the Contribution Plan. Participants may elect to contribute up to a maximum amount prescribed by the Code. The Company, at its discretion, makes matching contributions equal to the greater of 6% of the participant’s compensation. For the year ended December 31, 2021 and 2020, the Company made 401(k) plan contributions of approximately $1,455, $877 and $774 , respectively.

Shareholders_ equity (deficienc

Shareholders’ equity (deficiency) and redeemable convertible preferred shares	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Shareholders’ equity (deficiency) and redeemable convertible preferred shares	Note 12. Shareholders’ equity (deficiency) and redeemable convertible preferred shares a. Stock Split On August 30, 2021, the Company’s board of directors approved a 1:1.0422 reverse stock split. As a result, all ordinary shares, Preferred Shares, options for ordinary shares, restricted share unites,exercise price and net income (loss) per share amounts were adjusted retroactively for all periods presented in these condensed consolidated financial statements as if the stock split and change in par value had been in effect as of the date of these condensed consolidated interim financial statements. b. Ordinary Shares As of December 31, 2021 and 2020, the Company was authorized to issue 3,454,112,863 shares of par value NIS 0.00001 per share ordinary share. The voting, dividend and liquidation rights of the holders of the Company’s common stock is subject to and qualified by the rights, powers and preferences of the holders of the preferred stock as set forth below. Common stock confers upon its holders the following rights: i. The right to participate and vote in the Company’s general meetings. Each share will entitle its holder, when attending and participating in the voting to one vote; ii. Dividends or Distribution shall be paid or be made to the holders of Ordinary Shares, shall be in an amount equal the product of the dividend or distribution payable or made on each ordinary share determined as if all preferred shares had been converted into ordinary shares and the number of ordinary shares issuable upon conversion of such preferred share, in each case calculated on the record date for determination of holders entitled to receive such dividend or distribution; and iii. The right to a share in the distribution of the Company’s excess assets upon liquidation pro rata to the par value of the stock held by them. c. Redeemable Convertible Preferred shares rights On June 17, 2019, the Company issued 39,779,261 Convertible Preferred shares for $2.765 per share (the “Original Issue Price”) for the total consideration of $101,205 (net of issuance costs). On June 17, 2019, IGP Saferworld Limited Partnership (hereinafter: “IGP”), an investment vehicle of IGP Capital, a venture capital firm based in Israel, invested $110 million in the Company, in exchange for the Company’s redeemable convertible preferred shares, representing 24.4% of the Company’s outstanding ordinary and preferred shares (see also Note 3b and Note 12b). Following the IGP investment, the Company paid to its employees compensation in the amount of $4,034 includes in other expenses in the consolidated statements of operations and comprehensive income (loss). On August 30, 2021, immediately before the consummation of the Merger with TWC, the Company’s Preferred Shares were converted into Ordinary Shares. d. Acquisition of shares by the Company: During 2019, the Company acquired 295,000 shares from two of its shareholders, who were employed by the Company at the time of purchase. The shares were acquired in a price representing the fair value and the acquisition was presented as “Treasury stock”. The Treasury shares held by the Company were cancelled prior to the IGP investment as details in paragraph 12c. During 2020, the Company acquired 43,540 shares from one of its shareholders, who were employed by the Company at the time of purchase. e. Option Plan and RSU’s: .On June 17, 2019, the Company adopted a restricted share and restricted share units (“RSU”) Plan and a Share Option Plan. Under the RSU Plan, the maximum aggregate number of Shares that may be issued pursuant to awards under this plan shall initially be 5,756,855 authorized but unissued shares, or such other number as the Board may determine from time to time. As for the Share Option Plan, the Company has reserved a total of 20,761,094 Shares for the purposes of the Plan and for the purposes of any other equity incentive plans which may in the future be adopted by the Company. On August 1, 2021, The Company adopted the 2021 (the “2021 Plan). The 2021 plan provides for the grant of share options (including incentive share options and non-qualified share options), ordinary shares, RSUs and other share-based awards. The maximum aggregate number of shares that may be issued pursuant to awards under this 2021 Plan is 28,075,309. Employee Share Purchase Plan: In August 2021, the Company adopted the 2021 Employee Share Purchase Plan (“ESPP”) The aggregate number of Shares that may be issued pursuant to rights granted under the Plan shall be 1,871,687 Shares. In addition, on the first day of each calendar year beginning on January 1, 2023 and ending on and including January 1, 2033, the number of Shares available for issuance under the Plan shall be increased by that number of Shares equal to the lesser of (a) 1.0% of the Shares outstanding on the last day of the immediately preceding calendar year, as determined on a fully diluted basis, and (b) such smaller number of Shares as may be determined by the Board. If any right granted under the Plan shall for any reason terminate without having been exercised, the Shares not purchased under such right shall again become available for issuance under the Plan. The weighted-average fair value of stock-based compensation is based on the single option valuation approach and is estimated on the date of grant using a lattice based option valuation model. The fair value of options granted during the year ended December 31, 2021, December 31, 2020 and December 31, 2019 were calculated based on the following average assumptions: Year ended December 31, 2021 2020 2019 Contractual period in years 10 10 10 Volatility 35.9% - 52.7% 45.1% - 50.2% 43.1% - 45.2% Risk free interest rate 1.3% - 1.4% 0.1% - 1.0% 2.2% - 2.8% Dividend yield —% - 5% 0% - 5% 0% - 5% Exercise price $0.00 - $8.270 $2.385 - $5.190 $2.485 - $3.533 Fair value of Ordinary Share 5.41 - $8.270 $1.950 - $5.190 $2.032 - $3.533 Due to the dividend distribution adjustment mechanism, the exercise price is reduced according to the specific option agreement with each employee. The Company used estimated volatility of comparable public companies to estimate the expected volatility used for the lattice model. The risk-free interest rate assumption is based upon the US Treasury yield. As of December 31, 2021 the aggregate amount of options and RSU outstanding is 27,276,343. A summary of the Company’s option activity and related information is as follows: Number of options Weighted- average exercise price Weighted- average remaining contractual term (in years) Outstanding at December 31, 2020 30,834,504 $ 2.724 8.14 Granted 70,678 5.036 Exercised 2,626,573 2.661 Forfeited 2,790,712 2.874 Outstanding at December 31, 2021 25,487,897 $ 2.837 7.03 Exercisable at December 31, 2021 16,158,817 $ 2.643 6.45 Number of options Weighted- average exercise price Weighted- average remaining contractual term (in years) Outstanding at December 31, 2019 27,377,797 $ 3.033 8.59 Granted 9,909,539 2.215 Exercised 693,101 2.238 Forfeited 5,759,731 3.485 Outstanding at December 31, 2020 30,834,504 2.724 8.14 Exercisable at December 31, 2020 13,828,828 2.618 5.70 The weighted average fair values at grant date of options granted for the year ended December 31, 2021 and 2020; with an exercise price equal to the value at the date of grant were $5.04 and $0.74 per share, respectively. The total intrinsic value of options exercised during the years 2021 and 2020 was $8,547 and $2,171 respectively. The aggregate intrinsic value of the outstanding options at December 31, 2021 and 2020, represents the intrinsic value of 25,440,041 and 29,414,990, respectively, outstanding options that are in-the-money as of such dates. The remaining 70,678 and 143,939 outstanding options are out-of-the-money as of December 31, 2021 and 2020, respectively, and their intrinsic value was considered as zero. A summary of the Company’s RSUs activity is as follows: December 31, 2021 December 31, 2020 Unvested at beginning of year 893,629 1,898,810 Granted 1,393,208 257,638 Vested* 178,254 805,716 Forfeited 65,059 457,103 Unvested, at end of year 2,043,524 893,629 * 229,156 RSUs subject to deferral arrangements (“DSUs”) under the 2019 Restricted Share and Restricted Share Units Plan, that were vested as of Dec-31, 2020, and additional 43,356 DSUs that were vested in 2021 are not included in the count of shares, as according to that plan, upon their vesting they remain as a Share Unit and not converted into shares. The weighted average fair value at grant date of RSUs granted for the year ended December 31, 2020 and 2021 was $1.95 and $8.27 respectively The total fair value of shares vested during the years 2021 and 2020 was $927 and $4,327, respectively. As of December 31, 2021, the Company had approximately $20,316 of unrecognized compensation expense related to non-vested stock options and non-vested RSU’s, expected to be recognized over a weighted average period of 3.6 years. The Company did not recognize any tax benefit related to the share-based compensation. Subsequent to year end, during February, the Company’s board of directors approved additional grant 4,559,059 stock based compensation to its employees. f. Stock based compensation costs are recorded in the consolidated statements of operations were as follows: Year Ended December 31, 2021 2020 2019 Cost of revenues $ 290 $ 304 $ 190 Research and development 1,076 1,145 1,212 Sales and marketing 2,332 2,298 2,969 General and administrative 2,782 3,524 8,388 $ 6,480 $ 7,271 $ 12,759
Shareholders’ equity (deficiency) and redeemable convertible preferred shares	Note 12. Shareholders’ equity (deficiency) and redeemable convertible preferred shares a. Stock Split On August 30, 2021, the Company’s board of directors approved a 1:1.0422 reverse stock split. As a result, all ordinary shares, Preferred Shares, options for ordinary shares, restricted share unites,exercise price and net income (loss) per share amounts were adjusted retroactively for all periods presented in these condensed consolidated financial statements as if the stock split and change in par value had been in effect as of the date of these condensed consolidated interim financial statements. b. Ordinary Shares As of December 31, 2021 and 2020, the Company was authorized to issue 3,454,112,863 shares of par value NIS 0.00001 per share ordinary share. The voting, dividend and liquidation rights of the holders of the Company’s common stock is subject to and qualified by the rights, powers and preferences of the holders of the preferred stock as set forth below. Common stock confers upon its holders the following rights: i. The right to participate and vote in the Company’s general meetings. Each share will entitle its holder, when attending and participating in the voting to one vote; ii. Dividends or Distribution shall be paid or be made to the holders of Ordinary Shares, shall be in an amount equal the product of the dividend or distribution payable or made on each ordinary share determined as if all preferred shares had been converted into ordinary shares and the number of ordinary shares issuable upon conversion of such preferred share, in each case calculated on the record date for determination of holders entitled to receive such dividend or distribution; and iii. The right to a share in the distribution of the Company’s excess assets upon liquidation pro rata to the par value of the stock held by them. c. Redeemable Convertible Preferred shares rights On June 17, 2019, the Company issued 39,779,261 Convertible Preferred shares for $2.765 per share (the “Original Issue Price”) for the total consideration of $101,205 (net of issuance costs). On June 17, 2019, IGP Saferworld Limited Partnership (hereinafter: “IGP”), an investment vehicle of IGP Capital, a venture capital firm based in Israel, invested $110 million in the Company, in exchange for the Company’s redeemable convertible preferred shares, representing 24.4% of the Company’s outstanding ordinary and preferred shares (see also Note 3b and Note 12b). Following the IGP investment, the Company paid to its employees compensation in the amount of $4,034 includes in other expenses in the consolidated statements of operations and comprehensive income (loss). On August 30, 2021, immediately before the consummation of the Merger with TWC, the Company’s Preferred Shares were converted into Ordinary Shares. d. Acquisition of shares by the Company: During 2019, the Company acquired 295,000 shares from two of its shareholders, who were employed by the Company at the time of purchase. The shares were acquired in a price representing the fair value and the acquisition was presented as “Treasury stock”. The Treasury shares held by the Company were cancelled prior to the IGP investment as details in paragraph 12c. During 2020, the Company acquired 43,540 shares from one of its shareholders, who were employed by the Company at the time of purchase. e. Option Plan and RSU’s: .On June 17, 2019, the Company adopted a restricted share and restricted share units (“RSU”) Plan and a Share Option Plan. Under the RSU Plan, the maximum aggregate number of Shares that may be issued pursuant to awards under this plan shall initially be 5,756,855 authorized but unissued shares, or such other number as the Board may determine from time to time. As for the Share Option Plan, the Company has reserved a total of 20,761,094 Shares for the purposes of the Plan and for the purposes of any other equity incentive plans which may in the future be adopted by the Company. On August 1, 2021, The Company adopted the 2021 (the “2021 Plan). The 2021 plan provides for the grant of share options (including incentive share options and non-qualified share options), ordinary shares, RSUs and other share-based awards. The maximum aggregate number of shares that may be issued pursuant to awards under this 2021 Plan is 28,075,309. Employee Share Purchase Plan: In August 2021, the Company adopted the 2021 Employee Share Purchase Plan (“ESPP”) The aggregate number of Shares that may be issued pursuant to rights granted under the Plan shall be 1,871,687 Shares. In addition, on the first day of each calendar year beginning on January 1, 2023 and ending on and including January 1, 2033, the number of Shares available for issuance under the Plan shall be increased by that number of Shares equal to the lesser of (a) 1.0% of the Shares outstanding on the last day of the immediately preceding calendar year, as determined on a fully diluted basis, and (b) such smaller number of Shares as may be determined by the Board. If any right granted under the Plan shall for any reason terminate without having been exercised, the Shares not purchased under such right shall again become available for issuance under the Plan. The weighted-average fair value of stock-based compensation is based on the single option valuation approach and is estimated on the date of grant using a lattice based option valuation model. The fair value of options granted during the year ended December 31, 2021, December 31, 2020 and December 31, 2019 were calculated based on the following average assumptions: Year ended December 31, 2021 2020 2019 Contractual period in years 10 10 10 Volatility 35.9% - 52.7% 45.1% - 50.2% 43.1% - 45.2% Risk free interest rate 1.3% - 1.4% 0.1% - 1.0% 2.2% - 2.8% Dividend yield —% - 5% 0% - 5% 0% - 5% Exercise price $0.00 - $8.270 $2.385 - $5.190 $2.485 - $3.533 Fair value of Ordinary Share 5.41 - $8.270 $1.950 - $5.190 $2.032 - $3.533 Due to the dividend distribution adjustment mechanism, the exercise price is reduced according to the specific option agreement with each employee. The Company used estimated volatility of comparable public companies to estimate the expected volatility used for the lattice model. The risk-free interest rate assumption is based upon the US Treasury yield. As of December 31, 2021 the aggregate amount of options and RSU outstanding is 27,276,343. A summary of the Company’s option activity and related information is as follows: Number of options Weighted- average exercise price Weighted- average remaining contractual term (in years) Outstanding at December 31, 2020 30,834,504 $ 2.724 8.14 Granted 70,678 5.036 Exercised 2,626,573 2.661 Forfeited 2,790,712 2.874 Outstanding at December 31, 2021 25,487,897 $ 2.837 7.03 Exercisable at December 31, 2021 16,158,817 $ 2.643 6.45 Number of options Weighted- average exercise price Weighted- average remaining contractual term (in years) Outstanding at December 31, 2019 27,377,797 $ 3.033 8.59 Granted 9,909,539 2.215 Exercised 693,101 2.238 Forfeited 5,759,731 3.485 Outstanding at December 31, 2020 30,834,504 2.724 8.14 Exercisable at December 31, 2020 13,828,828 2.618 5.70 The weighted average fair values at grant date of options granted for the year ended December 31, 2021 and 2020; with an exercise price equal to the value at the date of grant were $5.04 and $0.74 per share, respectively. The total intrinsic value of options exercised during the years 2021 and 2020 was $8,547 and $2,171 respectively. The aggregate intrinsic value of the outstanding options at December 31, 2021 and 2020, represents the intrinsic value of 25,440,041 and 29,414,990, respectively, outstanding options that are in-the-money as of such dates. The remaining 70,678 and 143,939 outstanding options are out-of-the-money as of December 31, 2021 and 2020, respectively, and their intrinsic value was considered as zero. A summary of the Company’s RSUs activity is as follows: December 31, 2021 December 31, 2020 Unvested at beginning of year 893,629 1,898,810 Granted 1,393,208 257,638 Vested* 178,254 805,716 Forfeited 65,059 457,103 Unvested, at end of year 2,043,524 893,629 * 229,156 RSUs subject to deferral arrangements (“DSUs”) under the 2019 Restricted Share and Restricted Share Units Plan, that were vested as of Dec-31, 2020, and additional 43,356 DSUs that were vested in 2021 are not included in the count of shares, as according to that plan, upon their vesting they remain as a Share Unit and not converted into shares. The weighted average fair value at grant date of RSUs granted for the year ended December 31, 2020 and 2021 was $1.95 and $8.27 respectively The total fair value of shares vested during the years 2021 and 2020 was $927 and $4,327, respectively. As of December 31, 2021, the Company had approximately $20,316 of unrecognized compensation expense related to non-vested stock options and non-vested RSU’s, expected to be recognized over a weighted average period of 3.6 years. The Company did not recognize any tax benefit related to the share-based compensation. Subsequent to year end, during February, the Company’s board of directors approved additional grant 4,559,059 stock based compensation to its employees. f. Stock based compensation costs are recorded in the consolidated statements of operations were as follows: Year Ended December 31, 2021 2020 2019 Cost of revenues $ 290 $ 304 $ 190 Research and development 1,076 1,145 1,212 Sales and marketing 2,332 2,298 2,969 General and administrative 2,782 3,524 8,388 $ 6,480 $ 7,271 $ 12,759

Net income (loss) per share

Net income (loss) per share	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Net income (loss) per share	Note 13. Net income (loss) per share The following table sets forth the computation of basic losses per share: Year Ended December 31, 2021 2020 2019 Numerator: Net income (loss) $ 71,396 $ 5,781 $ (1,876) Basic net income attributable to Preferred shareholders — 15,125 8,163 Basic net income attributable to Restricted sponsor shares 963 — — Basic net income (loss) attributable to Ordinary shareholders 70,433 (9,344) (10,039) Denominator: Weighted average number of Ordinary shares used in computing basic net income (loss) per share 144,002,394 123,696,624 121,560,817 Basic net income (loss) per share of Ordinary shareholders $ 0.49 $ (0.08) $ (0.08) Weighted average number of Ordinary shares used in computing diluted net income (loss) per share 161,538,579 123,696,624 121,560,817 Diluted net income (loss) per share of Ordinary shareholders $ 0.44 $ (0.08) $ (0.08)

Revenues

Revenues	12 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Revenues	Note 14. Revenues Year Ended December 31, 2021 2020 2019 Revenues from subscription services $ 120,889 $ 100,614 $ 81,505 Revenues from term-license 62,428 29,131 5,142 Total revenues from subscription 183,317 129,745 86,647 Revenues from perpetual license and other 34,169 42,136 59,175 Revenues from professional services 28,760 23,032 26,032 $ 246,246 $ 194,913 $ 171,854 Including related party revenues in the amount of $3,678, $1,865 and $3,662 in 2021, 2020 and 2019, respectively.

Cost of revenues

Cost of revenues	12 Months Ended
	Dec. 31, 2021
Other Income and Expenses [Abstract]
Cost of revenues	Note 15. Cost of revenues Year Ended December 31, 2021 2020 2019 Materials and changes in inventories $ 10,316 $ 10,532 $ 7,638 Payroll and related expenses 19,754 17,019 14,272 Training expenses 3,885 2,713 5,338 Shipping expenses 1,548 1,543 1,784 Depreciation and Amortization 1,080 1,327 1,501 Inventory write-off 230 150 262 Travel 1,410 866 1,561 Other 4,334 3,729 3,467 $ 42,557 $ 37,879 $ 35,823 Cost of revenues by revenue type Year Ended December 31, 2021 2020 2019 Cost of revenues from subscription services $ 9,369 $ 8,795 $ 6,585 Cost of term-license 2,299 1,709 189 Cost of revenues from perpetual license and other 9,817 9,370 10,049 Cost of revenues from professional services 21,072 18,005 19,000 $ 42,557 $ 37,879 $ 35,823

Sales and marketing

Sales and marketing	12 Months Ended
	Dec. 31, 2021
Other Income and Expenses [Abstract]
Sales and marketing	Note 16. Sales and marketing Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 48,901 $ 39,991 $ 36,559 Sales commissions 10,312 8,246 6,624 Marketing and advertising 5,274 4,098 5,322 Travel and entertainment 2,279 1,276 4,939 Rent and maintenance 2,513 2,640 2,661 Depreciation and amortization 1,872 1,877 824 Vehicle costs 466 423 448 Professional consultants 1,349 808 1,889 Recruiting expenses 1,043 330 859 Other 2,380 1,616 1,485 $ 76,389 $ 61,305 $ 61,610 Note 17. Research and development Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 53,683 $ 45,716 39,142 Rent and maintenance 1,851 2,117 1,721 Subcontractors and projects 3,482 2,676 2,398 Travel and entertainment 185 20 314 Vehicle costs 232 270 355 Recruiting expenses 178 127 222 Depreciation and amortization 2,100 1,813 1,135 Other 3,830 1,638 1,286 $ 65,541 $ 54,377 $ 46,573 Note 18. General and administrative Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 19,366 $ 18,460 16,386 Professional fees 4,307 4,274 2,040 Vehicle costs 469 328 263 Rent and maintenance 1,559 2,147 2,071 Travel and entertainment 249 262 425 Refreshments, gifts and donations 525 778 645 Doubtful accounts and bad debts 676 606 266 Recruiting expenses 727 330 386 Depreciation 1,955 978 484 Issuance costs 11,835 — — Other 6,269 3,971 6,402 $ 47,937 $ 32,134 $ 29,368

Research and development

Research and development	12 Months Ended
	Dec. 31, 2021
Other Income and Expenses [Abstract]
Research and development	Note 16. Sales and marketing Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 48,901 $ 39,991 $ 36,559 Sales commissions 10,312 8,246 6,624 Marketing and advertising 5,274 4,098 5,322 Travel and entertainment 2,279 1,276 4,939 Rent and maintenance 2,513 2,640 2,661 Depreciation and amortization 1,872 1,877 824 Vehicle costs 466 423 448 Professional consultants 1,349 808 1,889 Recruiting expenses 1,043 330 859 Other 2,380 1,616 1,485 $ 76,389 $ 61,305 $ 61,610 Note 17. Research and development Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 53,683 $ 45,716 39,142 Rent and maintenance 1,851 2,117 1,721 Subcontractors and projects 3,482 2,676 2,398 Travel and entertainment 185 20 314 Vehicle costs 232 270 355 Recruiting expenses 178 127 222 Depreciation and amortization 2,100 1,813 1,135 Other 3,830 1,638 1,286 $ 65,541 $ 54,377 $ 46,573 Note 18. General and administrative Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 19,366 $ 18,460 16,386 Professional fees 4,307 4,274 2,040 Vehicle costs 469 328 263 Rent and maintenance 1,559 2,147 2,071 Travel and entertainment 249 262 425 Refreshments, gifts and donations 525 778 645 Doubtful accounts and bad debts 676 606 266 Recruiting expenses 727 330 386 Depreciation 1,955 978 484 Issuance costs 11,835 — — Other 6,269 3,971 6,402 $ 47,937 $ 32,134 $ 29,368

General and administrative

General and administrative	12 Months Ended
	Dec. 31, 2021
Other Income and Expenses [Abstract]
General and administrative	Note 16. Sales and marketing Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 48,901 $ 39,991 $ 36,559 Sales commissions 10,312 8,246 6,624 Marketing and advertising 5,274 4,098 5,322 Travel and entertainment 2,279 1,276 4,939 Rent and maintenance 2,513 2,640 2,661 Depreciation and amortization 1,872 1,877 824 Vehicle costs 466 423 448 Professional consultants 1,349 808 1,889 Recruiting expenses 1,043 330 859 Other 2,380 1,616 1,485 $ 76,389 $ 61,305 $ 61,610 Note 17. Research and development Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 53,683 $ 45,716 39,142 Rent and maintenance 1,851 2,117 1,721 Subcontractors and projects 3,482 2,676 2,398 Travel and entertainment 185 20 314 Vehicle costs 232 270 355 Recruiting expenses 178 127 222 Depreciation and amortization 2,100 1,813 1,135 Other 3,830 1,638 1,286 $ 65,541 $ 54,377 $ 46,573 Note 18. General and administrative Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 19,366 $ 18,460 16,386 Professional fees 4,307 4,274 2,040 Vehicle costs 469 328 263 Rent and maintenance 1,559 2,147 2,071 Travel and entertainment 249 262 425 Refreshments, gifts and donations 525 778 645 Doubtful accounts and bad debts 676 606 266 Recruiting expenses 727 330 386 Depreciation 1,955 978 484 Issuance costs 11,835 — — Other 6,269 3,971 6,402 $ 47,937 $ 32,134 $ 29,368

Financial income, net

Financial income, net	12 Months Ended
	Dec. 31, 2021
Nonoperating Income (Expense) [Abstract]
Financial income, net	Note 20. Financial income, net Year Ended December 31, 2021 2020 2019 Financial income: Interest on deposits $ 847 $ 2,710 $ 3,475 Foreign currency translation differences $ 51 780 380 Revaluation of liability instruments $ 67,873 — — Other $ 276 112 — Financial expenses: Bank charges $ (166) (197) (222) Changes in exchange rates $ (245) (1,226) (568) Other $ (153) — (130) $ 68,483 $ 2,179 $ 2,935

Dividend distribution

Dividend distribution	12 Months Ended
	Dec. 31, 2021
Dividends [Abstract]
Dividend distribution	Note 21. Dividend distribution In 2021 and 2020 the Board of Directors declared and distributed a dividend of $100,000 and $10,000, respectively, which were paid during the year. The dividend distributions were subject to a withholding tax at the shareholder’s level at the rate of 5%- 25%. See also note 3b.

Transactions and Balances_with

Transactions and Balances with Related Parties	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Transactions and Balances with Related Parties	Note 22. Transactions and Balances with Related Parties A. Transactions with SUN Corporation Year Ended December 31, 2021 December 31, 2020 December 31, 2019 Revenues 3,678 1,865 3,662 B. Balances with SUN Corporation December 31, 2021 December 31, 2020 Trade receivables 214 — Trade payables — (154)

Taxes on income

Taxes on income	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Taxes on income	Note 19. Taxes on income A. Israeli taxation 1. Corporate tax rates in Israel: The tax rates relevant to corporations in Israel in the years 2021, 2020 and 2019 is 23%. However, the effective tax rate reported by a company that derives income from a Preferred Enterprise or Preferred Technological Enterprise (as discussed below) is lower. 2. Tax benefits under the Law for Encouragement of Capital Investments, 1959 (“the Investment Law”) Approved/Beneficiary Enterprise Pursuant to the Investment Law, the Company was awarded “Approved Enterprise” and “Beneficiary Enterprise” status under the government alternative benefits path beginning in 2003 until 2018 (included). During this period the Company was entitled to beneficial tax rates of 0% – 10%. The Company decided to terminate its “Approved” and ”Beneficiary Enterprise” status early and enjoy beneficial tax rates under the “preferred technological enterprise” status effective beginning 2019. In the event of distribution of dividends from income taxable at 0% tax rate as part of the Approved Enterprise or Beneficiary Enterprise statuses, the amount distributed will be subject to corporate tax at the rate ordinarily applicable to the Approved or Beneficiary Enterprise’s. During the year ended December 31, 2021, the Company distributed approximately $71,000 attributable to these “trapped earnings” and recorded a related income tax expense of approximately $7,000. As of December 31, 2021, the Company has no remaining trapped earnings that would generate a tax liability, if distributed. On November 15, 2021, the Israeli Economic Efficiency Law for the years 2021 and 2022 was enacted, which consists of numerous legislative amendments and arrangements, including an amendment to Section 74 of the Encouragement Law, which deals with the identification of sources of dividend distributions as of August 15, 2021 (hereinafter - the amendment). The amendment stipulates that in any dividend distribution from companies holding accumulated profits that were exempt from tax until their distribution as a dividend ("trapped earnings"), a certain part of the distribution will be considered a distribution of those trapped earnings, which will be fully taxed upon release. In addition, a temporary provision to the Encouragement Law was enacted, which offers a reduced tax payment arrangement to companies that have trapped earnings. The temporary provision, which is valid until November 14, 2022, stipulates that companies that have chosen to apply it, will be entitled to a tax rebate on corporate income tax, for the released trapped earnings. The release of trapped earnings allows their distribution at a beneficiary corporate tax rate according to the ratio of the distributed profits. The beneficiary corporate tax will be determined according to the ratio of the trapped earnings that the company seeks to release from all its trapped earnings. It will range between 40% to 70% of the corporate tax rate that would have applied to income in the year it was generated, but in any case, not less than 6%. Eligibility for the beneficiary corporate tax rate is conditional on a company's decision to release part or all of its trapped earnings and the payment of the tax due until November 14, 2022, as well as on making investments in the companies' industrial plants over five years, in accordance with the formula set forth in the amendment. The Company might be eligible to a reduce tax for the trapped earning distributed on August 30, 2021 in the amount of $71,000 as detailed above Preferred Enterprise and Preferred Technology Enterprise Preferred Enterprise and Preferred Technology Enterprise On May 16, 2017 the Knesset Finance Committee approved Encouragement of Capital Investment Regulations (Preferred Technological Income and Capital Gain of Technological Enterprise) — 2017 (hereinafter: “the Regulations”), which provides rules for applying the “Preferred Technological Enterprise” tax benefit track including the formula that provides the mechanism for allocating the technological income eligible for the benefits Commencing in 2019 the Company elected the Preferred Technology Enterprise status to apply under the Law for the Encouragement of Capital Investments (the “Investment Law”). The approval is currently in affect for the tax years 2019 to 2023. The Company expects to continue to meet the conditions to be entitled to the “Preferred Technological Enterprise” status beyond 2023. Income subject to the Preferred Technology Enterprise status is taxed at reduced tax rate of 12% and income from manufacturing activity in Area A is taxed at reduced tax rate of 7.5%. 3. Foreign Exchange Regulations: Under the Foreign Exchange Regulations, the Company calculates its Israeli tax liability in U.S. dollars according to certain orders. The tax liability, as calculated in U.S. dollars is translated into NIS according to the exchange rate as of December 31 of each year. B. Income taxes on non-Israeli subsidiaries: The Company’s subsidiaries incorporated in the US, Germany, Singapore, Australia, Brazil, UK, France, Canada, Japan and India are taxed according to tax laws in the countries of their residence. The Company’s effective tax rate depends on the geographical mix of where its profits are earned. In the year 2021, the Company’s U.S. subsidiary is subject to combined federal and state income taxes of 26% and the subsidiaries in Germany and Singapore are subject to corporation tax at a rate of approximately 33% and 17% respectively. As of December 31, 2021, the Company had approximately $25,768 undistributed earnings of its subsidiaries for which a deferred tax liability of approximately $4,125 was not recognized. These undistributed earnings were designated as indefinitely reinvested. In the event of a distribution of those earnings in the form of dividends, a sale of the subsidiaries, or certain other transactions, we may be liable for income taxes, subject to an adjustment, if any, for foreign tax credits and foreign withholding taxes payable to certain foreign tax authorities C. Deferred taxes Deferred taxes recognized for the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and such amounts for income tax purposes. Significant components of the deferred tax liabilities and assets are as follows: December 31, 2021 December 31, 2020 Deferred tax assets: Deferred research and development cost $ 3,556 $ 4,970 Employee related liabilities 842 906 Intangible assets 1,125 1,304 Goodwill 2,773 1,354 Deferred revenues 1,765 1,164 Issuance costs 1,347 — Other 1,068 431 Total deferred tax assets 12,476 10,129 Deferred tax liabilities: Deferred costs 1,324 1,242 Intangible assets 545 771 Goodwill 180 68 Property and equipment 438 455 Derivative instruments 79 208 Other 110 13 Total deferred tax liabilities 2,676 2,757 Total deferred tax assets, net $ 9,800 $ 7,372 A reconciliation of the amount that would result from applying the Company’s e statutory tax rate in Israel to income before income tax expense to the reported amount of income tax expense allocated to continuing operations is as follows: Year Ended December 31, 2021 2020 2019 Income before income taxes expense, as reported in the consolidated statements of operations $ 82,305 $ 11,397 $ 1,415 Statutory tax rate in Israel 23 % 23 % 23 % Theoretical taxes on income 18,930 2,621 325 Foreign subsidiaries taxed at different tax rates 167 81 76 Preferred tax rates in Israel (7,598) (72) 937 Revaluation of liability instruments (8,145) — — Non-deductible expense 1,363 1,501 2,293 Taxes in respect of prior years (125) 78 (283) Intercompany transfer of intangible assets — 1,324 — Tax on dividend distributed from trapped earnings 7,068 — — Other (751) 83 (57) Actual income tax expense $ 10,909 $ 5,616 $ 3,291 Income before income tax expense is comprised as follows: Year Ended December 31, 2021 2020 2019 Domestic $ 71,434 $ 4,348 $ (3,920) Foreign 10,871 7,049 5,335 $ 82,305 $ 11,397 $ 1,415 Income tax expenses allocated to continuing operations is comprised as follows: Year Ended December 31, 2021 2020 2019 Current: Israel $ 9,665 $ 4,549 $ 3,950 Foreign 2,882 3,885 1,008 Total current tax expense: 12,547 8,434 4,958 Deferred: Israel (10) (3,729) (1,897) Foreign (1,628) 911 230 Total deferred tax benefit (1,638) (2,818) (1,667) Total income tax expense $ 10,909 $ 5,616 $ 3,291 A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits is as follows: December 31, 2021 December 31, 2020 Unrecognized tax benefits, beginning of year $ 2,007 $ 1,689 Decreases in tax positions for prior years — (388) Increases in tax positions for current year 1,231 706 Unrecognized tax benefits, end of year $ 3,238 $ 2,007 Interest expense recognized related to uncertain tax positions amounted to $92 , $25 and $51 in 2021 , 2020 and 2019, respectively. Total accrued interest as of December 31, 2021 and 2020 was $168 and $76, respectively, and were included in accrued expenses. The Company currently does not expect unrecognized tax benefits to change significantly over the next 12 months, except in the case of settlements with tax authorities, the likelihood and timing of which is difficult to estimate. The Company’s income tax assessments in Israel through the year 2016 are considered final and the Company is currently under routine income tax audit for tax years 2017-2018. The Company is subject to income tax in other jurisdictions outside of Israel, of which the major jurisdiction is the U.S. The Company’s operation in the US is subject to examination for tax years 2016 and afterwards. Timing of the resolution of audits is highly uncertain and therefore, as of December 31, 2021, the Company cannot estimate the change in unrecognized tax benefits resulting from these audits within the next 12 months.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Basis of presentation	The consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (US GAAP). The significant accounting policies followed in the preparation of the financial statements, applied on a consistent basis for all years presented in these financial statements.
Functional Currency and Foreign Currency Translation	A majority of the Company’s revenues are generated outside of Israel and are denominated in US dollars (“US$” or “dollars”). Substantial portion of materials and components cost, and marketing costs, are denominated in dollars or dollar-linked. Therefore, the Company’s management believes that the US dollars is the currency of the primary economic environment in which the Company operates. Thus, the functional currency and the reporting currency of the Company is the US dollar. Transactions in foreign currency are translated into dollars in accordance with the principles set forth in ASC Subtopic 830-20, Foreign Currency Transaction. Monetary assets and liabilities denominated in foreign currencies of the reporting date are translated to the functional currency at the closing rate at the end of the reporting period. Non-monetary assets and liabilities denominated in foreign currency are translated using the exchange rate at the date of the transaction. The effect of the translating into dollars has been included in the consolidated statements of shareholders’ equity and comprehensive income (loss) as a foreign currency translation adjustment. Gains and losses from remeasurement assets and liabilities denominated in currencies other than the respective functional currencies are included in the consolidated statements of operations.
Use of estimates	The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods and accompanying notes. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include, but are not limited to, the allocation of transaction price among various performance obligation, the fair value of acquired intangible assets and goodwill, share-based compensation, unrecognized tax benefits, fair value measurement of restricted sponsor shares liability, price adjustment shares liability and derivative warrant liabilities.
Principles of consolidation	The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances were eliminated in consolidation.
Cash and cash equivalents	The Company considers all highly liquid instruments with a maturity of three months or less at the date of purchase to be cash equivalents.
Restricted cash	Restricted cash consists of funds that are contractually restricted as to usage or withdrawal mainly due to a contractual agreement with an investor. The Company has presented restricted cash separately from cash and cash equivalents in the consolidated balance sheets.
Trade Receivable	Trade receivables are recorded at the invoiced amount net of allowance for doubtful accounts. The allowance for doubtful accounts is based on the Company’s assessment of in the collectability of accounts. The Company regularly reviews the adequacy of the allowance for doubtful accounts based on combination of factors, including as assessment of the current customer’s aging report, the nature and size of the customer, the financial condition of the customer and the amount of any receivables in dispute. Trade receivables deemed uncollectible are charged off against the allowance for doubtful accounts after all means of collection have been exhausted and the potential for recovery is considered remote.
Inventories	Inventories are stated at the lower of cost or net realizable value. Cost is determined by the “weighted moving average” method. Inventory write-downs are provided to cover technological obsolescence, excess inventories and discontinued products. Inventory write-down is measured as the difference between the cost of the inventory and market based upon assumptions about future demand, and is charged to cost of revenues. At the point of the loss recognition, a new, lower-cost basis for that inventory is established, and subsequent changes in facts and circumstances do not result in the restoration or increase in that newly established cost basis.
Property and equipment	Property and equipment are stated at cost less accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates: % Computers and software 12.5 – 33 Manufacturing equipment 7 Office furniture and equipment 7– 15 Leasehold improvements * *Over the shorter of the expected lease term or estimated useful lives.
Impairment of long-lived assets	Long-lived assets, such as property and equipment, and identifiable intangible assets subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable in accordance with ASC 360, Accounting for the impairment of Long-Lived Assets. If events of changes in the circumstances indicate that a long-lived asset or asset group value may not be recoverable, the Company compares aggregate undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If these cash flows are less than the carrying value, an impairment is recognized for the difference between the carrying value and the estimated fair value. Fair value is determined through discounted cash flow models and third-party independent appraisals, as considered necessary. The measurement of impairment requires management to estimate future cash flows and the fair value of long-lived assets. The evaluation is performed at the lowest levels for which there are identifiable, independent cash flows.
Revenue recognition	The Company’s revenues are comprised of four main categories: (a) subscription revenues, including support services (updates, upgrades and technical support) on term-based licenses and perpetual licenses; (b) subscription revenues also from sales of term-based licenses; (c) perpetual licenses (and others); and (d) professional services. The Company recognizes revenue pursuant to the five-step framework contained in ASC 606, Revenue from Contracts with Customers: (i) identify the contract with a client; (ii) identify the performance obligations in the contract, including whether they are distinct in the context of the contract; (iii) determine the transaction price, including the constraint on variable consideration; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the Company satisfies the performance obligations The Company sells its products to its customers either directly or indirectly through distribution channels all of whom are considered end users. In accordance with ASC 606, revenue is recognized when a customer obtains control of promised goods or services are delivered. The amount of revenue recognized reflects the consideration that the Company expects to receive in exchange for these goods or services. The Company determines that it has a contract with a customer when each party’s rights regarding the products or services to be transferred can be identified, the payment terms for the services can be identified, the Company has determined the customer has the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation. Performance obligations promised in a contract are identified based on the products and services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the products or services either on their own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the products and services is separately identifiable from other promises in the contract. The Company’s software licenses either provide its customers a perpetual right to use its software or the right to use its software for only a fixed term, in most cases between a one- and three-year time frame. The Company concluded that the software license is distinct as the customer can benefit from the software on its own. Support revenue is derived from providing technical customer support services, unspecified software updates and upgrades to customers several times a year, on a when-and-if-available basis. Performance obligations related to software maintenance services generally have a consistent continuous pattern of transfer to a customer during the contract period. Professional services revenues primarily consist of training and other professional services. Each of these performance obligations provide benefit to the customer on a standalone basis and are distinct in the context of the contract. The transaction price is determined based on the consideration to which the Company expects to be entitled in exchange for transferring products or delivery of services to the customer. Payment terms generally are net 30 days. The Company applied the practical expedient in ASC 606 and did not evaluate payment terms of one year or less for the existence of a significant financing component. Revenue is recognized net of any taxes collected from customers which are subsequently remitted to governmental entities (e.g., sales tax and other indirect taxes). The Company does not offer right of return to its contracts. If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. For contracts that contain multiple performance obligations, the Company allocates the transaction price to each performance obligation based on the relative standalone selling price (“SSP”) for each performance obligation. The Company uses judgment in determining the SSP for its products and services. The Company typically assesses the SSP for its products and services on a periodic basis or when facts and circumstances change. To determine SSP, the Company maximizes the use of observable standalone sales and observable data, where available. In instances where performance obligations do not have observable standalone sales, the Company utilizes available information that may include the entity specific factors such as assessment of historical data of bundled sales of software licenses with other promised goods and services, and pricing strategies to estimate the price the Company would charge if the products and services were sold separately. The Company satisfies performance obligations either over time or at a point in time depending on the nature of the underlying promise. Revenue is recognized at the time the related performance obligation is satisfied by transferring a promised good or service to a customer. Revenues related to the license for proprietary software are recognized when the control over the license is provided to the customer and the license term begins. Revenue related to software update and upgrades are recognized ratably over the service period. Revenues related to other professional services are generally recognized over time and in certain cases at point in time upon satisfaction of the performance obligation. Service revenues are included in the Company’s consolidated statements of income as service revenues. Contract assets consist of unbilled accounts receivable, which occur when a right to consideration for the Company’s performance under the customer contract occurs before invoicing to the customer. The increase in contract balances is consistent with the increase in the overall operation of the Company. Contract liabilities consist of deferred revenue. Revenue is deferred when the Company invoices in advance of performance under a contract. The current portion of the deferred revenue balance is recognized as revenue during the 12-month period after the balance sheet date. The non current The Company capitalizes sales commissions and associated payroll taxes paid to sales personnel that are incremental to obtaining customer contracts. These costs are recorded as deferred contract acquisition costs on the consolidated balance sheets. The Company determines whether costs should be deferred based on its sales compensation plans and if the commissions are incremental and would not have occurred absent the customer contract. Sales commissions for the renewal of a contract are considered commensurate with the sales commissions paid for the acquisition of the initial contract given no substantive difference in commission rates in proportion to their respective contract values. Sales commissions paid upon the initial acquisition and for the renewal of a contract are amortized over the contractual term of the initial contract or the renewal. Amortization of sales commissions are consistent with the pattern of revenue recognition of each performance obligation and are included in sales and marketing expense in the consolidated statements of operations. The Company periodically reviews these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. No impairment losses of capitalizes sales commissions were recorded during the periods presented.
Research and development costs	Research and development costs are expensed as incurred. As defined by ASC Subtopic 985-20 “Accounting for the Cost of Computer Software to be Sold, Leased or Otherwise Marketed”, costs associated with the development of computer software which are incurred subsequent to the establishment of technological feasibility, are capitalized thereafter until the product is available for general release to customers. Costs incurred by the Company between completion of the development and the point at which the product is ready for general release, have been insignificant. Therefore, all research and development costs are expensed as incurred.
Product warranties	The Company provides a one-year warranty on most of its products. Estimated future warranty costs are accrued and charged to cost of goods sold in the period that the related revenue is recognized. These estimates are derived from historical data and trends of product reliability and costs of repairing and replacing defective products.
Advertising expenses	Advertising expenses are charged to expense as incurred.
Income taxes	The Company accounts for income taxes in accordance with ASC 740, “Income Taxes”. ASC 740 prescribes the use of the liability method whereby deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period of enactment. A valuation allowance is provided, if necessary, to reduce deferred tax assets to the amount that is more likely than not to be realized. Deferred tax assets and deferred tax liabilities are presented under long-term assets. The Company implements a two-step approach to recognize and measure uncertainty in income taxes. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is greater than 50 percent (cumulative basis) likely to be realized upon settlement. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. The Company classifies interest and penalties related to unrecognized tax benefits as part of income taxes.
Stock-Based Compensation	The Company accounts for stock-based compensation in accordance with ASC Topic 718 (ASC718). ASC 718 requires that all stock-based compensation be recognized as an expense in the financial statements and that such cost be measured at the fair value of the award. The Company recognizes compensation expense on a straight line method. The fair value of the shares of ordinary shares underlying the stock options has historically been determined by the Company’s board of directors as there was no public market for the underlying ordinary shares. The Company’s board of directors determines the fair value of the Company’s ordinary shares by considering a number of objective and subjective factors including: contemporaneous third-party valuations of its ordinary shares, the valuation of comparable companies, sales of the Company’s ordinary and redeemable convertible preferred shares to outside investors in arms-length transactions, the Company’s operating and financial performance, the lack of marketability, and general and industry specific economic outlook, amongst other factors. For all share options granted, the Company calculated the expected term using the simplified method for “plain vanilla” stock option awards. The risk-free interest rate is based on the yield available on U.S. Treasury zero-coupon issues similar in duration to the expected term of the stock-based award. The Company calculates the fair value of share options on the date of grant using the Black-Scholes option-pricing model and the expense is recognized over the requisite service period for awards expected to vest using the straight line method. The Company utilized a dividend yield of 0-5%. Stock based compensation costs have been included in income from operations.
Fair value measurements	The Company accounts for fair value in accordance with ASC 820, “Fair Value Measurements and Disclosures”. Fair value is defined under ASC 820 as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value under ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows: • Level 1: Quoted prices in active markets for identical assets or liabilities. • Level 2: Inputs other than Level 1 inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the asset or liability. • Level 3: Unobservable inputs for the asset or liability used to measure fair value that are supported by little or no market activity and that re significant to the fair value of the asset or liability at measurement date. The first two levels in the hierarchy are considered observable inputs and the last is considered unobservable. The carrying value of accounts receivable and payables and the Company’s cash and cash equivalents, restricted cash and short-term investments, approximates fair value due to the short time to expected payment or receipt of cash. Derivative warrant liabilities Upon the closing of the transaction, 20,000,000 public warrants and 9,666,667 private warrants, that were both issued by TWC prior to the transaction, were outstanding to purchase the Company’s ordinary shares. Each warrant entitles the holder to purchase one Company Ordinary Share at a price of $11.50 per share, subject to adjustments. The warrants are exercisable at any time commencing 30 days after the completion of the transaction and expire five years after the Closing Date or earlier upon redemption or liquidation. The Company may redeem the outstanding public warrants in whole and not in part at a price of $0.01 per warrant at any time after they become exercisable, provided that the last sale price of the Company ordinary shares equals or exceeds $18 per share, subject to adjustments, for any 20-trading days within a 30-trading day period ending three business days prior to the date on which the Company sends the notice of redemption to the warrant holders. The private warrants have similar terms as the public warrants, except that the private warrants may be exercised for cash or on a cashless basis at the holder’s option and the private warrants will not be redeemed by the Company as long as they are held by the initial purchasers or their permitted transferees, but once they are transferred, they have the same rights as the public warrants. As the private warrants include provisions that provide for potential changes to the settlement amounts that are dependent on the characteristics of the holder of the warrant, under ASC Section 815-40, those warrants are not indexed to the Company’s ordinary shares in the manner contemplated by that Section, so long as they are held by the initial purchasers or their permitted transferees. The Public Warrants may be exercised with a different mechanism, depends on whether the Company maintain an effective registration statement or not. Since, among other things, the fact whether the Company maintains an effective registration statement effect the settlement provision of the Public Warrants (i.e., the cap is applicable depends on whether the registration statement is effective or not), is not an input into the pricing of fixed for fixed option model on equity shares, the Public Warrants are precluded from being indexed to the Company's own stock and should be classified as a liability. Therefore, the public and private warrants were classified as a liability measured at fair value pursuant to ASC 480 “Distinguishing Liabilities from Equity” and ASC 815 “Derivatives and Hedging”. Public Warrants Private Placement Warrants Total Derivative Warrant liability Warrant liability assumed from the Business Combination $ 34,400 $ 34,045 $ 68,445 Change in fair value of warrant liability 800 (12,767) (11,967) Balance, December 31, 2021 $ 35,200 $ 21,278 $ 56,478 The estimated fair value of the private placement warrant derivative liabilities is determined using Level 3 inputs. Inherent in a Black-Scholes valuation model are assumptions related to expected stock-price volatility, expiration, risk-free interest rate and dividend yield. The Company estimates the volatility of its common stock based on historical volatility of select peer companies that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. Treasury zero-coupon yield curve on the grant date for a maturity similar to the expiration of the warrants. The dividend yield is based on the historical rate, which the Company anticipates will remain at 0-5%. The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: As of December 31, 2021 Number of private placement warrants 9,666,667 Exercise price $11.5 Share price $8.02 Expiration term (in years) 4.66 Volatility 44.8% Risk-free Rate 1.22% Dividend yield 0% - 5% Restricted sponsor shares liability and Price adjustment shares 7,500,000 Ordinary Shares issued to the Sponsor, out of a total of 13,500,000 shares, are Restricted Shares and will vest in 3 tranches of 3,000,000, 3,000,000 and 1,500,000, upon achievement of the of the triggering events (as defined in the business combination agreement); if at any time during the Price Adjustment Period the price of Cellebrite Ordinary Shares will be greater than or equal to $12.50, $15.00 and $30.00, respectively, over any twenty trading days within any thirty trading day period. In the event of a post-Closing change of control transaction involving the Company, any Restricted Shares not previously vested will vest and will be entitled to participate in the change of control transaction. The probability of such event was considered by the Company. Upon the expiration of the Price Adjustment Period (a period of seven years), any unvested Cellebrite Shares that have not vested as of such time will be forfeited. Cellebrite security holders shall be entitled to vote their unvested Restricted Shares and receive dividends and other distribution, and to have all other economic rights, in each case, with respect to such Restricted Shares while they remain unvested. Holders of the Company’s Ordinary Shares and vested Restricted Share Units, in each case as of immediately prior to the effective time, are eligible to receive up to 15,000,000 Ordinary Shares that will vest in 3 tranches of 5,000,000 upon achievement of the of the triggering events (if at any time during the Price Adjustment Period the price of Cellebrite Ordinary Shares will be greater than or equal to $12.50, $15.00 and $30.00, respectively, over any twenty trading days within any thirty trading day period.) or upon a Change of Control (as defined in business combination agreement) before the five Following the Merger, the Company issued equity and debt instrument. Transaction expenses were allocated on a relative fair value basis. Restricted sponsor shares Price adjustment shares Total Earn out shares assumed from the Business Combination $ 62,347 $ 117,675 $ 180,022 Change in fair value of warrant liability (17,635) (38,271) (55,906) Balance, December 31, 2021 $ 44,712 $ 79,404 $ 124,116
Derivative instruments	The Company has instituted a foreign currency cash flow hedging program using foreign currency forward contracts (“derivative instruments”) in order to hedge the exposure to variability in expected future cash flows resulting from changes in related foreign currency exchange rates. The Company hedges portions of its forecasted expenses denominated in NIS. These transactions are designated as cash flow hedges, as defined under ASC 815, “Derivatives and Hedging” .
Goodwill	Goodwill represents the excess of the purchase price in a business combination over the fair value of the net tangible and intangible assets acquired. Under ASC 350, “Intangible — Goodwill and Other”, goodwill is not amortized, but rather is subject to an annual impairment test. ASC 350 requires goodwill to be tested for impairment at the reporting unit level at least annually, the fourth quarter, or between annual tests in certain circumstances, and written down when impaired. Goodwill is tested for impairment by comparing the fair value of the reporting unit with its carrying value. The Company has determined that it has one operating segment and one reporting unit. ASC 350 allows an entity to first assess qualitative factors to determine whether it is necessary to perform the two-step quantitative goodwill impairment test. If the qualitative assessment does not result in a more likely than not indication of impairment, no further impairment testing is required. If it does result in a more likely than not indication of impairment, the two-step impairment test is performed. Alternatively, ASC 350 permits an entity to bypass the qualitative assessment for any reporting unit and proceed directly to performing the first step of the goodwill impairment test. There were no impairment charges to goodwill during the period presented.
Intangible assets	Intangible assets are amortized over their estimated useful lives using the straight-line method, at the following annual period ranges: Years Core technology 5- 7 Trade name 4 Customer relationship 10 Each period the Company evaluates the estimated remaining useful lives of its intangible assets and whether events or changes in circumstances warrant a revision to the remaining period of amortization.
Business combination	The Company applies the provisions of ASC 805, “Business Combination” and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, the Company estimated the future expected cash flows from acquired core technology and acquired trade name from a market participant perspective, useful lives and discount rates. In addition, management makes significant estimates and assumptions, which are uncertain, but believed to be reasonable. Significant estimates in valuing certain intangible assets include, but are not limited to future expected cash flows from acquired technology and acquired trademarks from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Acquisition-related costs are recognized separately from the acquisition and are expensed as incurred.
Concentrations of credit risk	Financial instruments that potentially expose the Company and its subsidiaries to concentrations of credit risk consist principally of cash and cash equivalents, short-term investments, restricted cash, trade receivables and other receivables. The majority of the Company’s cash and cash equivalents are maintained in U.S. dollar. Generally, these cash and cash equivalents and short term investment may be redeemed upon demand. Management believes that the financial institutions that hold the Company’s and its subsidiaries’ cash and cash equivalents are institutions with high credit standing, and accordingly, minimal credit risk exists with respect to these assets. The Company’s trade receivables are geographically diversified and derived from sales to customers all over the world. The Company and its subsidiaries generally do not require collateral; however, in certain circumstances, the Company and its subsidiaries may require letters of credit, additional guarantees or advance payments.
Segment reporting	The Company identifies operating segments in accordance with ASC Topic 280, “Segment Reporting” as components of an entity for which discrete financial information is available and is regularly reviewed by the chief operating decision maker, or decision-making group, in making decisions regarding resource allocation and evaluating financial performance. The Company defines the term “chief operating decision maker” to be its chief executive officer. The Company determined it operates in one operating segment and one reportable segment, as its chief operating decision maker reviews financial information presented only on a consolidated basis for purposes of allocating resources and evaluating financial performance.
Basic and diluted net income (loss) per share	The Company computes basic income (loss) per share in accordance with ASC Topic 260, “Earnings per Share” by dividing the income (loss) attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the year. Diluted income (loss) per share is computed by taking into account the potential dilution that could occur upon the exercise of share options and vesting of RSUs granted under share based compensation plans using the treasury stock method. Basic and diluted income (loss) per share was presented in conformity with the two class method for participating securities for the year ended December 31, 2021, 2020 and 2019, as a result of a dividend distribution. The potentially dilutive share options to purchase ordinary shares that were excluded from the computation amounted to 9,995,236, 31,728,133 and 29,276,607 for the years ended December 31, 2021, 2020 and 2019, respectively, because including them would have been anti dilutive. The Earn-Out Shares, which were subject to the occurrence of certain conditions, were excluded from the diluted net income per share calculation for the year ended December 31, 2021, because the Earn-Out Shares conditions were not met at the end of the reporting period. Public warrants and Private warrants, were excluded from the diluted income per share for the year ended December 31, 2021, as the inclusion would have been anti dilutive.
Recently issued accounting pronouncements	As an “Emerging growth company,” the Jumpstart Our Business Startups Act (“JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The Company has elected to use this extended transition period under the JOBS Act. The adoption dates discussed below reflect this election. Recently adopted accounting pronouncements: On October 28, 2021, the FASB issued ASU 2021-08, which amends ASC 805 to require acquiring entities to apply ASC 606 to recognize and measure contract assets and contract liabilities in a business combination. Under previously effective GAAP, an acquirer recognizes such items at fair value on the acquisition date. ASU 2021-08 amends ASC 805 to add contract assets and contract liabilities to the list of exceptions to the recognition and measurement principles that apply to business combinations and to require that an entity (acquirer) recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC 606. The Company allocated the transaction price to each performance obligation based on the standalone selling price at the acquisition date. As a result of the amendments, it is expected that an acquirer will generally recognize and measure acquired contract assets and contract liabilities (deferred revenue) in a manner consistent with how the acquiree recognized and measured them in its preacquisition financial statements. In addition, as a result of the amendment, acquirer likely would subsequently recognize the same amount of revenue that the acquiree would have recognized if no business combination took place. The ASU will be effective for fiscal years beginning after December 15, 2022 and interim periods therein for public business entities. The Company early adopted the standard in 2021. Acquisitions of businesses assumed during the year ended December 31, 2021 were presented in conformity with the provisions of the standard. Recently issued accounting pronouncements not yet adopted: In February 2016, the FASB issued ASU 2016-02, “Leases” (“ASC 842”), on the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e., lessees and lessors). The new standard requires lessees to apply a dual approach, classifying leases as either finance or operating leases based on the principle of whether or not the lease is effectively a financed purchase by the lessee. This classification will determine whether lease expense is recognized based on an effective interest method or on a straight line basis over the term of the lease, respectively. A lessee is also required to record a right-of-use asset and a lease liability for all leases with a term of greater than 12 months regardless of their classification. Leases with a term of twelve (12) months or less will be accounted for in a manner similar to the accounting under the prior guidance (ASC 840). The new standard requires lessors to account for leases using an approach that is substantially equivalent to ASC 840 guidance for sales-type leases, direct financing leases and operating leases. The new standard supersedes the previous leases standard, ASC 840, “Leases”. The standard is effective for the annual periods beginning on or after January 1, 2022. The Company expects adoption of the ASU to have a material impact on its consolidated balance sheet, which will result in the recognition of ROU assets and lease liabilities of approximately $16,400 on January 1, 2022. The main impact of the ASU pertains to the recognition of an ROU asset and a lease liability arising from the Company’s office building lease agreement. Further, the Company expects its financial income (expenses), net to be impacted by foreign exchange gain and losses arising from its non-USD denominated lease liabilities. In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 amends the impairment model to utilize an expected loss methodology in place of the currently used incurred loss methodology, which will result in the more timely recognition of losses. The new accounting standard will be effective for the fiscal year beginning on January 1, 2023, including interim periods within that year. The Company does not plan to early adopt the ASU and is assessing the impact of the standard. In December 2019, the FASB issued ASU 2019-12 to simplify the accounting for income taxes. The guidance eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. The guidance also simplifies aspects of accounting for taxes partially based on income and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. The standard will be effective for the Company beginning January 1, 2022. The Company does not expect this standard to have a significant impact on the Company’s consolidated financial statements.
Reclassifications	Certain comparative figures have been reclassified to conform to the current year presentation.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Property and Equipment	Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates: % Computers and software 12.5 – 33 Manufacturing equipment 7 Office furniture and equipment 7– 15 Leasehold improvements * *Over the shorter of the expected lease term or estimated useful lives. December 31, 2021 December 31, 2020 Manufacturing equipment $ 526 $ 509 Furniture and equipment 8,294 6,898 Leasehold improvements 6,637 6,430 Computers and software 22,735 18,931 38,192 32,768 Less—accumulated depreciation (21,436) (16,662) $ 16,756 $ 16,106
Disaggregation of Revenue	The following table provides information about disaggregated revenue by geographical areas Year Ended December 31, 2021 2020 2019 EMEA $ 88,441 $ 65,807 $ 55,911 America 126,929 100,835 89,514 APAC 30,876 28,271 26,429 Total $ 246,246 $ 194,913 $ 171,854
Summary of Contract Balances	The following table provides information about accounts receivable, contract assets, and contract liabilities from contracts with customers: December 31, 2021 December 31, 2020 Contract assets $ 8,567 $ 3,967 Contract liabilities, current 122,983 105,543 Contract liabilities, non-current $ 36,426 $ 33,439
Summary of the Change in the Fair Value of Liabilities	Public Warrants Private Placement Warrants Total Derivative Warrant liability Warrant liability assumed from the Business Combination $ 34,400 $ 34,045 $ 68,445 Change in fair value of warrant liability 800 (12,767) (11,967) Balance, December 31, 2021 $ 35,200 $ 21,278 $ 56,478 Following the Merger, the Company issued equity and debt instrument. Transaction expenses were allocated on a relative fair value basis. Restricted sponsor shares Price adjustment shares Total Earn out shares assumed from the Business Combination $ 62,347 $ 117,675 $ 180,022 Change in fair value of warrant liability (17,635) (38,271) (55,906) Balance, December 31, 2021 $ 44,712 $ 79,404 $ 124,116
Summary of Fair Value Measurement Inputs and Valuation Techniques	The following table provides quantitative information regarding Level 3 fair value measurements inputs as their measurement dates: As of December 31, 2021 Number of private placement warrants 9,666,667 Exercise price $11.5 Share price $8.02 Expiration term (in years) 4.66 Volatility 44.8% Risk-free Rate 1.22% Dividend yield 0% - 5%
Schedule of Finite-Lived Intangible Assets	Intangible assets are amortized over their estimated useful lives using the straight-line method, at the following annual period ranges: Years Core technology 5- 7 Trade name 4 Customer relationship 10 Definite-lived intangible assets: December 31, 2021 December 31, 2020 Original amounts: Core technology $ 10,411 $ 4,000 Trade name 3,900 3,900 Customer relationship 177 — 14,488 7,900 Accumulated amortization: Core technology 1,470 476 Trade name 1,788 813 Customer relationship 2 — 3,260 1,289 Intangible assets, net $ 11,228 $ 6,611

Business combination (Tables)

Business combination (Tables)	12 Months Ended
	Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The purchase price allocation for the acquisition has been determined as follows: Amount Net assets $ (890) Technology 3,347 Customer relationship 177 Goodwill 17,366 Total $ 20,000
Summary of Identifiable Intangible Assets Acquired	The following table sets forth the components of identifiable intangible assets acquired and their estimated useful lives as of the date of acquisition: Fair Value Useful Life US$ thousands In years Core technology 3,347 7 Customer relationship 177 10 Total identifiable intangible assets $ 3,524

Intangible assets, net (Tables)

Intangible assets, net (Tables)	12 Months Ended
	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Definite-Lived Intangible Assets	Intangible assets are amortized over their estimated useful lives using the straight-line method, at the following annual period ranges: Years Core technology 5- 7 Trade name 4 Customer relationship 10 Definite-lived intangible assets: December 31, 2021 December 31, 2020 Original amounts: Core technology $ 10,411 $ 4,000 Trade name 3,900 3,900 Customer relationship 177 — 14,488 7,900 Accumulated amortization: Core technology 1,470 476 Trade name 1,788 813 Customer relationship 2 — 3,260 1,289 Intangible assets, net $ 11,228 $ 6,611
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	December 31, 2021 are as follows: 2022 $ 2,655 2023 2,655 2024 1,843 2025 1,680 2026 and thereafter 2,395 $ 11,228

Prepaid expenses and other cu_2

Prepaid expenses and other current assets (Tables)	12 Months Ended
	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Prepaid Expenses and Other Current Assets	December 31, 2021 December 31, 2020 Advances to suppliers $ 827 $ 163 Prepaid expenses 8,927 4,319 Government institutions 1,662 811 Other 1,402 2,146 $ 12,818 $ 7,439

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2021
Inventory Disclosure [Abstract]
Schedule of Inventory	December 31, 2021 December 31, 2020 Raw materials $ 4,742 $ 3,279 Finished goods 1,769 1,475 $ 6,511 $ 4,754

Property and equipment, net (Ta

Property and equipment, net (Tables)	12 Months Ended
	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Property and Equipment	Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following annual rates: % Computers and software 12.5 – 33 Manufacturing equipment 7 Office furniture and equipment 7– 15 Leasehold improvements * *Over the shorter of the expected lease term or estimated useful lives. December 31, 2021 December 31, 2020 Manufacturing equipment $ 526 $ 509 Furniture and equipment 8,294 6,898 Leasehold improvements 6,637 6,430 Computers and software 22,735 18,931 38,192 32,768 Less—accumulated depreciation (21,436) (16,662) $ 16,756 $ 16,106

Other accounts payable and ac_2

Other accounts payable and accrued expenses (Tables)	12 Months Ended
	Dec. 31, 2021
Payables and Accruals [Abstract]
Schedule of Other Accounts Payable and Accrued Expenses	December 31, 2021 December 31, 2020 Governmental institution $ 2,372 $ 2,192 Employees and related expenses 29,725 28,098 Income tax payable 8,235 6,610 Accrued expenses 12,800 11,037 Phantom option units liability — 538 Advances from customers 695 559 Other 217 78 $ 54,044 $ 49,112

Commitments (Tables)

Commitments (Tables)	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases	Future minimum lease commitments under non-cancellable operating leases as of December 31, 2021, are as follows: US$ thousands 2022 $ 4,890 2023 4,251 2024 5,417 2025 2,221 2026 and thereafter 1,722 $ 18,501

Shareholders_ equity (deficie_2

Shareholders’ equity (deficiency) and redeemable convertible preferred shares (Tables)	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
Temporary Equity
Summary of Assumptions Used to Calculate the Fair Value of Options Granted	The fair value of options granted during the year ended December 31, 2021, December 31, 2020 and December 31, 2019 were calculated based on the following average assumptions: Year ended December 31, 2021 2020 2019 Contractual period in years 10 10 10 Volatility 35.9% - 52.7% 45.1% - 50.2% 43.1% - 45.2% Risk free interest rate 1.3% - 1.4% 0.1% - 1.0% 2.2% - 2.8% Dividend yield —% - 5% 0% - 5% 0% - 5% Exercise price $0.00 - $8.270 $2.385 - $5.190 $2.485 - $3.533 Fair value of Ordinary Share 5.41 - $8.270 $1.950 - $5.190 $2.032 - $3.533
Schedule of Stock Option Activity	A summary of the Company’s option activity and related information is as follows: Number of options Weighted- average exercise price Weighted- average remaining contractual term (in years) Outstanding at December 31, 2020 30,834,504 $ 2.724 8.14 Granted 70,678 5.036 Exercised 2,626,573 2.661 Forfeited 2,790,712 2.874 Outstanding at December 31, 2021 25,487,897 $ 2.837 7.03 Exercisable at December 31, 2021 16,158,817 $ 2.643 6.45 Number of options Weighted- average exercise price Weighted- average remaining contractual term (in years) Outstanding at December 31, 2019 27,377,797 $ 3.033 8.59 Granted 9,909,539 2.215 Exercised 693,101 2.238 Forfeited 5,759,731 3.485 Outstanding at December 31, 2020 30,834,504 2.724 8.14 Exercisable at December 31, 2020 13,828,828 2.618 5.70
Schedule of Nonvested Restricted Stock Units Activity	A summary of the Company’s RSUs activity is as follows: December 31, 2021 December 31, 2020 Unvested at beginning of year 893,629 1,898,810 Granted 1,393,208 257,638 Vested* 178,254 805,716 Forfeited 65,059 457,103 Unvested, at end of year 2,043,524 893,629 * 229,156 RSUs subject to deferral arrangements (“DSUs”) under the 2019 Restricted Share and Restricted Share Units Plan, that were vested as of Dec-31, 2020, and additional 43,356 DSUs that were vested in 2021 are not included in the count of shares, as according to that plan, upon their vesting they remain as a Share Unit and not converted into shares.
Summary of Stock-Based Compensation	Stock based compensation costs are recorded in the consolidated statements of operations were as follows: Year Ended December 31, 2021 2020 2019 Cost of revenues $ 290 $ 304 $ 190 Research and development 1,076 1,145 1,212 Sales and marketing 2,332 2,298 2,969 General and administrative 2,782 3,524 8,388 $ 6,480 $ 7,271 $ 12,759

Net income (loss) per share (Ta

Net income (loss) per share (Tables)	12 Months Ended
	Dec. 31, 2021
Earnings Per Share [Abstract]
Summary of the Computation of Basic Losses Per Share	The following table sets forth the computation of basic losses per share: Year Ended December 31, 2021 2020 2019 Numerator: Net income (loss) $ 71,396 $ 5,781 $ (1,876) Basic net income attributable to Preferred shareholders — 15,125 8,163 Basic net income attributable to Restricted sponsor shares 963 — — Basic net income (loss) attributable to Ordinary shareholders 70,433 (9,344) (10,039) Denominator: Weighted average number of Ordinary shares used in computing basic net income (loss) per share 144,002,394 123,696,624 121,560,817 Basic net income (loss) per share of Ordinary shareholders $ 0.49 $ (0.08) $ (0.08) Weighted average number of Ordinary shares used in computing diluted net income (loss) per share 161,538,579 123,696,624 121,560,817 Diluted net income (loss) per share of Ordinary shareholders $ 0.44 $ (0.08) $ (0.08)

Revenues (Tables)

Revenues (Tables)	12 Months Ended
	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Revenue from External Customers by Products and Services	Year Ended December 31, 2021 2020 2019 Revenues from subscription services $ 120,889 $ 100,614 $ 81,505 Revenues from term-license 62,428 29,131 5,142 Total revenues from subscription 183,317 129,745 86,647 Revenues from perpetual license and other 34,169 42,136 59,175 Revenues from professional services 28,760 23,032 26,032 $ 246,246 $ 194,913 $ 171,854

Cost of revenues (Tables)

Cost of revenues (Tables)	12 Months Ended
	Dec. 31, 2021
Other Income and Expenses [Abstract]
Schedule of Cost of Revenues	Year Ended December 31, 2021 2020 2019 Materials and changes in inventories $ 10,316 $ 10,532 $ 7,638 Payroll and related expenses 19,754 17,019 14,272 Training expenses 3,885 2,713 5,338 Shipping expenses 1,548 1,543 1,784 Depreciation and Amortization 1,080 1,327 1,501 Inventory write-off 230 150 262 Travel 1,410 866 1,561 Other 4,334 3,729 3,467 $ 42,557 $ 37,879 $ 35,823 Cost of revenues by revenue type Year Ended December 31, 2021 2020 2019 Cost of revenues from subscription services $ 9,369 $ 8,795 $ 6,585 Cost of term-license 2,299 1,709 189 Cost of revenues from perpetual license and other 9,817 9,370 10,049 Cost of revenues from professional services 21,072 18,005 19,000 $ 42,557 $ 37,879 $ 35,823

Sales and marketing (Tables)

Sales and marketing (Tables)	12 Months Ended
	Dec. 31, 2021
Other Income and Expenses [Abstract]
Summary of Sales and Marketing Expense	Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 48,901 $ 39,991 $ 36,559 Sales commissions 10,312 8,246 6,624 Marketing and advertising 5,274 4,098 5,322 Travel and entertainment 2,279 1,276 4,939 Rent and maintenance 2,513 2,640 2,661 Depreciation and amortization 1,872 1,877 824 Vehicle costs 466 423 448 Professional consultants 1,349 808 1,889 Recruiting expenses 1,043 330 859 Other 2,380 1,616 1,485 $ 76,389 $ 61,305 $ 61,610 Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 53,683 $ 45,716 39,142 Rent and maintenance 1,851 2,117 1,721 Subcontractors and projects 3,482 2,676 2,398 Travel and entertainment 185 20 314 Vehicle costs 232 270 355 Recruiting expenses 178 127 222 Depreciation and amortization 2,100 1,813 1,135 Other 3,830 1,638 1,286 $ 65,541 $ 54,377 $ 46,573 Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 19,366 $ 18,460 16,386 Professional fees 4,307 4,274 2,040 Vehicle costs 469 328 263 Rent and maintenance 1,559 2,147 2,071 Travel and entertainment 249 262 425 Refreshments, gifts and donations 525 778 645 Doubtful accounts and bad debts 676 606 266 Recruiting expenses 727 330 386 Depreciation 1,955 978 484 Issuance costs 11,835 — — Other 6,269 3,971 6,402 $ 47,937 $ 32,134 $ 29,368

Research and development (Table

Research and development (Tables)	12 Months Ended
	Dec. 31, 2021
Other Income and Expenses [Abstract]
Summary of Research and Development Expense	Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 48,901 $ 39,991 $ 36,559 Sales commissions 10,312 8,246 6,624 Marketing and advertising 5,274 4,098 5,322 Travel and entertainment 2,279 1,276 4,939 Rent and maintenance 2,513 2,640 2,661 Depreciation and amortization 1,872 1,877 824 Vehicle costs 466 423 448 Professional consultants 1,349 808 1,889 Recruiting expenses 1,043 330 859 Other 2,380 1,616 1,485 $ 76,389 $ 61,305 $ 61,610 Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 53,683 $ 45,716 39,142 Rent and maintenance 1,851 2,117 1,721 Subcontractors and projects 3,482 2,676 2,398 Travel and entertainment 185 20 314 Vehicle costs 232 270 355 Recruiting expenses 178 127 222 Depreciation and amortization 2,100 1,813 1,135 Other 3,830 1,638 1,286 $ 65,541 $ 54,377 $ 46,573 Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 19,366 $ 18,460 16,386 Professional fees 4,307 4,274 2,040 Vehicle costs 469 328 263 Rent and maintenance 1,559 2,147 2,071 Travel and entertainment 249 262 425 Refreshments, gifts and donations 525 778 645 Doubtful accounts and bad debts 676 606 266 Recruiting expenses 727 330 386 Depreciation 1,955 978 484 Issuance costs 11,835 — — Other 6,269 3,971 6,402 $ 47,937 $ 32,134 $ 29,368

General and administrative (Tab

General and administrative (Tables)	12 Months Ended
	Dec. 31, 2021
Other Income and Expenses [Abstract]
Summary of General and Administrative Expense	Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 48,901 $ 39,991 $ 36,559 Sales commissions 10,312 8,246 6,624 Marketing and advertising 5,274 4,098 5,322 Travel and entertainment 2,279 1,276 4,939 Rent and maintenance 2,513 2,640 2,661 Depreciation and amortization 1,872 1,877 824 Vehicle costs 466 423 448 Professional consultants 1,349 808 1,889 Recruiting expenses 1,043 330 859 Other 2,380 1,616 1,485 $ 76,389 $ 61,305 $ 61,610 Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 53,683 $ 45,716 39,142 Rent and maintenance 1,851 2,117 1,721 Subcontractors and projects 3,482 2,676 2,398 Travel and entertainment 185 20 314 Vehicle costs 232 270 355 Recruiting expenses 178 127 222 Depreciation and amortization 2,100 1,813 1,135 Other 3,830 1,638 1,286 $ 65,541 $ 54,377 $ 46,573 Year Ended December 31, 2021 2020 2019 Payroll and related expenses $ 19,366 $ 18,460 16,386 Professional fees 4,307 4,274 2,040 Vehicle costs 469 328 263 Rent and maintenance 1,559 2,147 2,071 Travel and entertainment 249 262 425 Refreshments, gifts and donations 525 778 645 Doubtful accounts and bad debts 676 606 266 Recruiting expenses 727 330 386 Depreciation 1,955 978 484 Issuance costs 11,835 — — Other 6,269 3,971 6,402 $ 47,937 $ 32,134 $ 29,368

Financial income, net (Tables)

Financial income, net (Tables)	12 Months Ended
	Dec. 31, 2021
Nonoperating Income (Expense) [Abstract]
Schedule of Net Financial Income	Year Ended December 31, 2021 2020 2019 Financial income: Interest on deposits $ 847 $ 2,710 $ 3,475 Foreign currency translation differences $ 51 780 380 Revaluation of liability instruments $ 67,873 — — Other $ 276 112 — Financial expenses: Bank charges $ (166) (197) (222) Changes in exchange rates $ (245) (1,226) (568) Other $ (153) — (130) $ 68,483 $ 2,179 $ 2,935

Transactions and Balances_wit_2

Transactions and Balances with Related Parties (Tables)	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	Year Ended December 31, 2021 December 31, 2020 December 31, 2019 Revenues 3,678 1,865 3,662 December 31, 2021 December 31, 2020 Trade receivables 214 — Trade payables — (154)

Taxes on income (Tables)

Taxes on income (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
Schedule of Deferred Tax Assets and Liabilities	Significant components of the deferred tax liabilities and assets are as follows: December 31, 2021 December 31, 2020 Deferred tax assets: Deferred research and development cost $ 3,556 $ 4,970 Employee related liabilities 842 906 Intangible assets 1,125 1,304 Goodwill 2,773 1,354 Deferred revenues 1,765 1,164 Issuance costs 1,347 — Other 1,068 431 Total deferred tax assets 12,476 10,129 Deferred tax liabilities: Deferred costs 1,324 1,242 Intangible assets 545 771 Goodwill 180 68 Property and equipment 438 455 Derivative instruments 79 208 Other 110 13 Total deferred tax liabilities 2,676 2,757 Total deferred tax assets, net $ 9,800 $ 7,372
Schedule of Effective Income Tax Rate Reconciliation	A reconciliation of the amount that would result from applying the Company’s e statutory tax rate in Israel to income before income tax expense to the reported amount of income tax expense allocated to continuing operations is as follows: Year Ended December 31, 2021 2020 2019 Income before income taxes expense, as reported in the consolidated statements of operations $ 82,305 $ 11,397 $ 1,415 Statutory tax rate in Israel 23 % 23 % 23 % Theoretical taxes on income 18,930 2,621 325 Foreign subsidiaries taxed at different tax rates 167 81 76 Preferred tax rates in Israel (7,598) (72) 937 Revaluation of liability instruments (8,145) — — Non-deductible expense 1,363 1,501 2,293 Taxes in respect of prior years (125) 78 (283) Intercompany transfer of intangible assets — 1,324 — Tax on dividend distributed from trapped earnings 7,068 — — Other (751) 83 (57) Actual income tax expense $ 10,909 $ 5,616 $ 3,291
Schedule of Income before Income Tax, Domestic and Foreign	Income before income tax expense is comprised as follows: Year Ended December 31, 2021 2020 2019 Domestic $ 71,434 $ 4,348 $ (3,920) Foreign 10,871 7,049 5,335 $ 82,305 $ 11,397 $ 1,415
Schedule of Components of Income Tax Expense (Benefit)	Income tax expenses allocated to continuing operations is comprised as follows: Year Ended December 31, 2021 2020 2019 Current: Israel $ 9,665 $ 4,549 $ 3,950 Foreign 2,882 3,885 1,008 Total current tax expense: 12,547 8,434 4,958 Deferred: Israel (10) (3,729) (1,897) Foreign (1,628) 911 230 Total deferred tax benefit (1,638) (2,818) (1,667) Total income tax expense $ 10,909 $ 5,616 $ 3,291
Schedule of Unrecognized Tax Benefits Roll Forward	A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits is as follows: December 31, 2021 December 31, 2020 Unrecognized tax benefits, beginning of year $ 2,007 $ 1,689 Decreases in tax positions for prior years — (388) Increases in tax positions for current year 1,231 706 Unrecognized tax benefits, end of year $ 3,238 $ 2,007

General (Details)

General (Details) - USD ($) $ in Thousands	Nov. 11, 2021	Feb. 28, 2020	Feb. 27, 2020
BlackBag Technologies Inc. (“BlackBag”)
Business Acquisition [Line Items]
Percentage of voting interests acquired		100.00%	100.00%
Total consideration transferred		$ 33,362
Digital Clues (“DC”)
Business Acquisition [Line Items]
Total consideration transferred	$ 20,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Impairment of Long-Lived Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Asset impairment charges	$ 0	$ 0	$ 0

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Property and Equipment (Details)	12 Months Ended
	Dec. 31, 2021
Computers and software | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	12.50%
Computers and software | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	33.00%
Manufacturing equipment
Property, Plant and Equipment [Line Items]
Estimated useful lives	7.00%
Office furniture and equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives	7.00%
Office furniture and equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives	15.00%

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Revenue Recognition Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Performance obligation, description of timing	The Company’s software licenses either provide its customers a perpetual right to use its software or the right to use its software for only a fixed term, in most cases between a one- and three-year time frame.
Advances from customers		$ 138,982	$ 159,409
Contract with customer, liability, revenue recognized	$ 97,823	61,964
Revenue, remaining performance obligation amount	231,666	172,885
Unbilled revenue	72,257	33,903
Capitalized sales commission, impairment loss	0	0
Capitalized contract cost amortization	$ 10,700	$ 8,400	$ 6,800
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01
Revenue, Initial Application Period Cumulative Effect Transition [Line Items]
Revenue, remaining performance obligation, percentage	61.00%
Revenue, remaining performance obligation, expected timing of satisfaction, period	1 year

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Schedule of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disaggregation of Revenue [Line Items]
Total revenue	$ 246,246	$ 194,913	$ 171,854
EMEA
Disaggregation of Revenue [Line Items]
Total revenue	88,441	65,807	55,911
America
Disaggregation of Revenue [Line Items]
Total revenue	126,929	100,835	89,514
APAC
Disaggregation of Revenue [Line Items]
Total revenue	$ 30,876	$ 28,271	$ 26,429

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Schedule of Contract Balances (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Contract assets	$ 8,567	$ 3,967
Contract liabilities, current	122,983	105,543
Contract liabilities, non-current	$ 36,426	$ 33,439

Summary of Significant Accoun_9

Summary of Significant Accounting Policies - Advertising Expenses and Stock-based Compensation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Standard product warranty term	1 year
Advertising expense	$ 5,274	$ 4,098	$ 5,315
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	0.00%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	5.00%

Summary of Significant Accou_10

Summary of Significant Accounting Policies - Fair Value Measurements Narrative (Details)	Aug. 30, 2021₪ / sharesshares	Dec. 31, 2021tradingDay$ / sharesshares	Aug. 30, 2021$ / sharesshares
Class of Warrant or Right [Line Items]
Number of securities issued per warrant exercised (in shares)	1		1
Exercise price (USD per share) | ₪ / shares	₪ 11.50
Days after completion of transaction in which award is exercisable	30 days
Expiration period	5 years
Price per share, company redemption option (USD per share) | $ / shares			$ 0.01
Minimum share price of company stock, in which company can redeem warrants (USD per share) | $ / shares			$ 18
Trading days within a 30-trading day period	20 days
Trading day period	30 days
The Sponsor | TWC Tech Holdings II Corp. (“TWC")
Class of Warrant or Right [Line Items]
Contingent consideration (in shares)		13,500,000
The Sponsor | TWC Tech Holdings II Corp. (“TWC") | Restricted stock
Class of Warrant or Right [Line Items]
Contingent consideration (in shares)		7,500,000
Contingent consideration threshold trading days | tradingDay		20
Contingent consideration threshold consecutive trading days | tradingDay		30
Contingent consideration price adjustment expiration period		7 years
The Sponsor | TWC Tech Holdings II Corp. (“TWC") | Restricted stock | Reverse recapitalization agreement, tranche one
Class of Warrant or Right [Line Items]
Contingent consideration (in shares)		3,000,000
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares		$ 12.50
The Sponsor | TWC Tech Holdings II Corp. (“TWC") | Restricted stock | Reverse recapitalization agreement, tranche two
Class of Warrant or Right [Line Items]
Contingent consideration (in shares)		3,000,000
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares		$ 15
The Sponsor | TWC Tech Holdings II Corp. (“TWC") | Restricted stock | Reverse recapitalization agreement, tranche three
Class of Warrant or Right [Line Items]
Contingent consideration (in shares)		1,500,000
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares		$ 30
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units | TWC Tech Holdings II Corp. (“TWC") | Ordinary shares and vested restricted stock units
Class of Warrant or Right [Line Items]
Contingent consideration (in shares)		15,000,000
Contingent consideration threshold trading days | tradingDay		20
Contingent consideration threshold consecutive trading days | tradingDay		30
Contingent consideration terms, performance period		5 years
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units | TWC Tech Holdings II Corp. (“TWC") | Ordinary shares and vested restricted stock units | Reverse recapitalization agreement, tranche one
Class of Warrant or Right [Line Items]
Contingent consideration (in shares)		5,000,000
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares		$ 12.50
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units | TWC Tech Holdings II Corp. (“TWC") | Ordinary shares and vested restricted stock units | Reverse recapitalization agreement, tranche two
Class of Warrant or Right [Line Items]
Contingent consideration (in shares)		5,000,000
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares		$ 15
Holders of Cellebrite’s ordinary shares and vested Restricted Share Units | TWC Tech Holdings II Corp. (“TWC") | Ordinary shares and vested restricted stock units | Reverse recapitalization agreement, tranche three
Class of Warrant or Right [Line Items]
Contingent consideration (in shares)		5,000,000
Contingent consideration terms, stock price trigger (in USD per share) | $ / shares		$ 30
Public Warrants
Class of Warrant or Right [Line Items]
Number of private placement warrants	20,000,000		20,000,000
Private Placement Warrants
Class of Warrant or Right [Line Items]
Number of private placement warrants	9,666,667		9,666,667

Summary of Significant Accou_11

Summary of Significant Accounting Policies - Summary of Changes in Fair Value of Derivative Warrant Liabilities (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Change in fair value of warrant liability	$ 67,873	$ 0	$ 0
Warrants to purchase ordinary shares | Total Derivative Warrant liability
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Warrant liability assumed from the Business Combination	68,445
Change in fair value of warrant liability	(11,967)
Balance, December 31, 2021	56,478
Warrants to purchase ordinary shares | Public Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Warrant liability assumed from the Business Combination	34,400
Change in fair value of warrant liability	800
Balance, December 31, 2021	35,200
Warrants to purchase ordinary shares | Private Placement Warrants
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Warrant liability assumed from the Business Combination	34,045
Change in fair value of warrant liability	(12,767)
Balance, December 31, 2021	$ 21,278

Summary of Significant Accou_12

Summary of Significant Accounting Policies - Schedule of Fair Value Inputs (Details) - Private Placement Warrants	Dec. 31, 2021$ / sharesyrshares	Aug. 30, 2021shares
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of private placement warrants | shares		9,666,667
Warrants to purchase ordinary shares | Fair Value, Inputs, Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Number of private placement warrants | shares	9,666,667
Warrants to purchase ordinary shares | Fair Value, Inputs, Level 3 | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0
Warrants to purchase ordinary shares | Fair Value, Inputs, Level 3 | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.05
Warrants to purchase ordinary shares | Fair Value, Inputs, Level 3 | Exercise price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input | $ / shares	11.5
Warrants to purchase ordinary shares | Fair Value, Inputs, Level 3 | Share price
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input | $ / shares	8.02
Warrants to purchase ordinary shares | Fair Value, Inputs, Level 3 | Expiration term (in years)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input | yr	4.66
Warrants to purchase ordinary shares | Fair Value, Inputs, Level 3 | Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.448
Warrants to purchase ordinary shares | Fair Value, Inputs, Level 3 | Risk-free Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.0122
Warrants to purchase ordinary shares | Fair Value, Inputs, Level 3 | Dividend yield | Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0
Warrants to purchase ordinary shares | Fair Value, Inputs, Level 3 | Dividend yield | Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative liability, measurement input	0.05

Summary of Significant Accou_13

Summary of Significant Accounting Policies- Summary of Changes in Fair Value of Restricted Sponsor Shares (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Change in fair value of warrant liability	$ 67,873	$ 0	$ 0
Restricted Sponsor And Price Adjustment Shares
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Earn out shares assumed from the Business Combination	180,022
Change in fair value of warrant liability	(55,906)
Balance, December 31, 2021	124,116
Restricted sponsor shares
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Earn out shares assumed from the Business Combination	62,347
Change in fair value of warrant liability	(17,635)
Balance, December 31, 2021	44,712
Price adjustment shares
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Earn out shares assumed from the Business Combination	117,675
Change in fair value of warrant liability	(38,271)
Balance, December 31, 2021	$ 79,404

Summary of Significant Accou_14

Summary of Significant Accounting Policies - Restricted Sponsor Shares Liability (Details) - TWC Tech Holdings II Corp. (“TWC") - The Sponsor	12 Months Ended
	Dec. 31, 2021shares
Business Acquisition [Line Items]
Contingent consideration (in shares)	13,500,000
Restricted stock
Business Acquisition [Line Items]
Contingent consideration (in shares)	7,500,000

Summary of Significant Accou_15

Summary of Significant Accounting Policies - Derivative Instruments (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Derivative [Line Items]
Unrealized gain on hedging transactions, net	$ (944)
Unrealized gain on hedging transactions, net		$ 1,212	$ 620
Derivative, notional amount	15,623
Derivative asset	964	2,016
Foreign Exchange Forward
Derivative [Line Items]
Unrealized gain on hedging transactions, net	$ 577
Unrealized gain on hedging transactions, net		$ 1,521

Summary of Significant Accou_16

Summary of Significant Accounting Policies - Goodwill (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2021USD ($)segmentreportingUnit
Accounting Policies [Abstract]
Number of operating segments | segment	1
Number of reporting units | reportingUnit	1
Goodwill impairment loss | $	$ 0

Summary of Significant Accou_17

Summary of Significant Accounting Policies - Intangible Assets (Details)	12 Months Ended
	Dec. 31, 2021
Core technology | Minimum
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	5 years
Core technology | Maximum
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	7 years
Trade name
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	4 years
Customer relationship
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangible asset, useful life	10 years

Summary of Significant Accou_18

Summary of Significant Accounting Policies - Segment Reporting (Details)	12 Months Ended
	Dec. 31, 2021segment
Accounting Policies [Abstract]
Number of operating segments	1
Number of reportable segments	1

Summary of Significant Accou_19

Summary of Significant Accounting Policies - Basic and Diluted Net Income (Loss) per Share (Details) - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Accounting Policies [Abstract]
Antidilutive securities excluded from computation of earnings per share (in shares)	9,995,236	31,728,133	29,276,607

Summary of Significant Accou_20

Summary of Significant Accounting Policies - Recently Issued Accounting Pronouncements (Details) - Forecast $ in Thousands	Jan. 01, 2022USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Right of use asset	$ 16,400
Lease liability	$ 16,400

Business combination - Narrativ

Business combination - Narrative (Details) $ / shares in Units, $ in Thousands	Nov. 11, 2021USD ($)	Aug. 30, 2021USD ($)$ / sharesshares	Feb. 28, 2020USD ($)	Feb. 27, 2020USD ($)installment	Dec. 31, 2021USD ($)	Dec. 31, 2020USD ($)		Dec. 31, 2019USD ($)	Dec. 31, 2021₪ / shares	Dec. 31, 2020₪ / shares
Business Acquisition [Line Items]
Number of installments | installment				3
Goodwill					$ 26,829	$ 9,463	[1]
Amortization expense					1,971	1,289		$ 0
Payment of dividend					100,000	10,000		$ 25,000
Common stock par value per share (in USD per share) | (per share)		$ 10							₪ 0.00001	₪ 0.00001
PIPE Investor, Share Purchase Agreement
Business Acquisition [Line Items]
Sale of stock, price per share (in USD per share) | $ / shares		$ 10
Number of shares issued in transaction (in shares) | shares		30,000,000
Sale of stock, consideration received		$ 300,000
Conversion of stock, shares converted (in shares) | shares		30,000,000
Initial dividend paid
Business Acquisition [Line Items]
Payment of dividend		$ 21,300,000
Additional dividend paid
Business Acquisition [Line Items]
Payment of dividend		$ 78,700,000
BlackBag Technologies Inc. (“BlackBag”)
Business Acquisition [Line Items]
Percentage of voting interests acquired			100.00%	100.00%
Consideration transferred, including contingent consideration				$ 33,362
Cash consideration transferred				15,362
Consideration to be paid in installments				18,000
Consideration transferred, installment payments				6,000
Contingent consideration liability				$ 13,000
Contingent consideration, performance period				2 years
Acquisition related costs						1,848
Goodwill				$ 9,463
Amortization expense					1,289	$ 1,546
Total consideration transferred			$ 33,362
BlackBag Technologies Inc. (“BlackBag”) | Trade name
Business Acquisition [Line Items]
Intangible assets acquired				$ 4,000
Useful Life				4 years
BlackBag Technologies Inc. (“BlackBag”) | Core technology
Business Acquisition [Line Items]
Intangible assets acquired				$ 3,900
Useful Life				7 years
TWC Tech Holdings II Corp. (“TWC") | TWC Securityholders
Business Acquisition [Line Items]
Recapitalization exchange ratio (in shares) | shares		1
Digital Clues LTD
Business Acquisition [Line Items]
Acquisition related costs					267
Intangible assets acquired	$ 3,524
Goodwill	17,366
Amortization expense					$ 67
Total consideration transferred	20,000
Digital Clues LTD | Core technology
Business Acquisition [Line Items]
Intangible assets acquired	$ 3,347
Useful Life	7 years
[1]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 12, Shareholders’ Equity, for details .

Business combination - Schedule

Business combination - Schedule of Purchase Price Allocation Digital Clues LTD (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Nov. 11, 2021	Dec. 31, 2020	[1]
Business Acquisition [Line Items]
Goodwill	$ 26,829		$ 9,463
Digital Clues LTD
Business Acquisition [Line Items]
Net assets		$ (890)
Intangible assets acquired		3,524
Goodwill		17,366
Total		20,000
Digital Clues LTD | Core technology
Business Acquisition [Line Items]
Intangible assets acquired		3,347
Digital Clues LTD | Customer relationship
Business Acquisition [Line Items]
Intangible assets acquired		$ 177
[1]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 12, Shareholders’ Equity, for details .

Business combination - Intangib

Business combination - Intangible Assets Acquired (Details) - Digital Clues LTD $ in Thousands	Nov. 11, 2021USD ($)
Business Acquisition [Line Items]
Intangible assets acquired	$ 3,524
Core technology
Business Acquisition [Line Items]
Intangible assets acquired	$ 3,347
Useful Life	7 years
Customer relationship
Business Acquisition [Line Items]
Intangible assets acquired	$ 177
Useful Life	10 years

Intangible assets, net - Schedu

Intangible assets, net - Schedule of Definite-Lived Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]
Gross amounts	$ 14,488	$ 7,900
Accumulated amortization	3,260	1,289
Intangible assets, net	11,228	6,611
Core technology
Finite-Lived Intangible Assets [Line Items]
Gross amounts	10,411	4,000
Accumulated amortization	1,470	476
Trade name
Finite-Lived Intangible Assets [Line Items]
Gross amounts	3,900	3,900
Accumulated amortization	1,788	813
Customer relationship
Finite-Lived Intangible Assets [Line Items]
Gross amounts	177	0
Accumulated amortization	$ 2	$ 0

Intangible assets, net - Sche_2

Intangible assets, net - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 1,971	$ 1,289	$ 0
2022	2,655
2023	2,655
2024	1,843
2025	1,680
2026 and thereafter	2,395
Intangible assets, net	$ 11,228	$ 6,611

Short-term deposits (Details)

Short-term deposits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash and Cash Equivalents [Line Items]
Short-term deposits	$ 35,592	$ 108,928	[1]
Minimum
Cash and Cash Equivalents [Line Items]
Deposits interest rates	0.10%	0.27%
Maximum
Cash and Cash Equivalents [Line Items]
Deposits interest rates	1.55%	2.47%
[1]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 12, Shareholders’ Equity, for details .

Prepaid expenses and other cu_3

Prepaid expenses and other current assets - Schedule of Prepayments and Other Current Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Advances to suppliers	$ 827	$ 163
Prepaid expenses	8,927	4,319
Government institutions	1,662	811
Other	1,402	2,146
Prepaid expenses and other current assets	$ 12,818	$ 7,439	[1]
[1]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 12, Shareholders’ Equity, for details .

Inventories - Schedule of Inven

Inventories - Schedule of Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Inventory Disclosure [Abstract]
Raw materials	$ 4,742	$ 3,279
Finished goods	1,769	1,475
Total inventory	$ 6,511	$ 4,754	[1]
[1]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 12, Shareholders’ Equity, for details .

Property and equipment, net (De

Property and equipment, net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020		Dec. 31, 2019
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 38,192	$ 32,768
Less—accumulated depreciation	(21,436)	(16,662)
Property, plant and equipment, net	16,756	16,106	[1]
Depreciation	5,036	4,464		$ 3,587
Manufacturing equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	526	509
Furniture and equipment
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	8,294	6,898
Leasehold improvements
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	6,637	6,430
Computers and software
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 22,735	$ 18,931
[1]	Prior period results have been retroactively adjusted to reflect the 1:1.0422 reverse stock split effected on August 30, 2021. See also Note 12, Shareholders’ Equity, for details .

Other accounts payable and ac_3

Other accounts payable and accrued expenses - Schedule of Accounts Payable and Accruals (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Payables and Accruals [Abstract]
Governmental institution	$ 2,372	$ 2,192
Employees and related expenses	29,725	28,098
Income tax payable	8,235	6,610
Accrued expenses	12,800	11,037
Phantom option units liability	0	538
Advances from customers	695	559
Other	217	78
Other accounts payable and accrued expenses	$ 54,044	$ 49,112

Commitments - Operating Lease C

Commitments - Operating Lease Commitments (Details) $ in Thousands	Dec. 31, 2021USD ($)
Commitments and Contingencies Disclosure [Abstract]
2022	$ 4,890
2023	4,251
2024	5,417
2025	2,221
2026 and thereafter	1,722
Total	$ 18,501

Liability for employees sever_2

Liability for employees severance benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Postemployment Benefits [Abstract]
Severance pay expense	$ 4,067	$ 3,340	$ 3,476
Employer matching contribution, percent of employees' gross pay	6.00%
Defined contribution plan, employer contributions	$ 1,455	$ 877	$ 774

Shareholders_ equity (deficie_3

Shareholders’ equity (deficiency) and redeemable convertible preferred shares - Narrative (Details) $ / shares in Units, $ in Thousands

Aug. 30, 2021$ / shares

Jun. 17, 2019USD ($)$ / sharesshares

Feb. 28, 2022shares

Aug. 31, 2021shares

Dec. 31, 2021USD ($)vote$ / shares

Dec. 31, 2020USD ($)shareholder$ / sharesshares

Dec. 31, 2019USD ($)shareholdershares

Dec. 31, 2021₪ / shares

Dec. 31, 2021USD ($)shares

Aug. 01, 2021shares

Dec. 31, 2020₪ / shares

Dec. 31, 2020USD ($)shares

Class of Stock [Line Items]

Reverse stock split, conversion ratio

0.9595

Common stock, shares authorized (in shares)

3,454,112,863

3,454,112,863

Common stock par value per share (in NIS per share) | (per share)

$ 10

₪ 0.00001

₪ 0.00001

Number of votes per share | vote

1

Issuance of redeemable convertible preferred shares (in shares)

39,779,261

39,779,261

Temporary equity issued during period, price per share (in USD per share) | $ / shares

$ 2.765

Issuance of redeemable convertible preferred shares | $

$ 101,205

$ 101,205

Proceeds from issuance of redeemable convertible preferred stock | $

110,000

Employee compensation paid after the issuance of redeemable convertible preferred shares | $

$ 4,034

Treasury stock, shares acquired (in shares)

43,540

295,000

Number of shareholders | shareholder

1

2

Shares, options and RSUs outstanding (in shares)

27,276,343

Grants in period, weighted average grant date fair value (in USD per share) | $ / shares

$ 5.04

$ 0.74

Options, intrinsic value of exercises in period | $

$ 8,547

$ 2,171

Options outstanding (in shares)

27,377,797

25,487,897

30,834,504

Share-based payment arrangement, cost not yet recognized | $

$ 20,316

Expected period for recognition

3 years 7 months 6 days

Subsequent event

Class of Stock [Line Items]

Share-based compensation arrangement, number of additional shares authorized (in shares)

4,559,059

The 2021 Plan

Class of Stock [Line Items]

Share-based compensation arrangement, shares authorized (in shares)

28,075,309

Share Option Plan And Other Equity Incentive Plans

Class of Stock [Line Items]

Share-based compensation arrangement, shares authorized (in shares)

20,761,094

Restricted Stock Units (RSUs)

Class of Stock [Line Items]

Grants in period, Weighted average grant date fair value (in USD per share) | $ / shares

$ 8.27

$ 1.95

Equity instruments other than options, vested in period, fair value | $

$ 927

$ 4,327

Restricted Stock Units (RSUs) | RSU Plan

Class of Stock [Line Items]

Share-based compensation arrangement, shares authorized (in shares)

5,756,855

Employee Stock

Class of Stock [Line Items]

Share-based compensation arrangement, shares authorized (in shares)

1,871,687

Number of shares authorized (in shares)

1.00%

Options, in-the-money

Class of Stock [Line Items]

Options outstanding (in shares)

25,440,041

29,414,990

Options, out-of-the-money

Class of Stock [Line Items]

Options outstanding (in shares)

70,678

143,939

Options outstanding, aggregate intrinsic value | $

$ 0

$ 0

Cellebrite DI Ltd | IGP Saferworld Limited Partnership

Class of Stock [Line Items]

Temporary equity, common and preferred share equivalent ownership percentage

24.40%

Shareholders_ equity (deficie_4

Shareholders’ equity (deficiency) and redeemable convertible preferred shares - Schedule of Fair Value Assumptions (Details) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options exercised, Weighted average exercise price per share (in USD per share)	$ 2.661	$ 2.238
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	0.00%
Options exercised, Weighted average exercise price per share (in USD per share)	$ 0	2.385	$ 2.485
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	5.00%
Options exercised, Weighted average exercise price per share (in USD per share)	$ 8.270	$ 5.190	$ 3.533
Share-based payment arrangement, option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contractual period in years	10 years	10 years	10 years
Share-based payment arrangement, option | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	35.90%	45.10%	43.10%
Risk free interest rate	1.30%	0.10%	2.20%
Dividend yield	0.00%	0.00%	0.00%
Fair value of Ordinary Share (in USD per share)	$ 5.41	$ 1.950	$ 2.032
Share-based payment arrangement, option | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility	52.70%	50.20%	45.20%
Risk free interest rate	1.40%	1.00%	2.80%
Dividend yield	5.00%	5.00%	5.00%
Fair value of Ordinary Share (in USD per share)	$ 8.270	$ 5.190	$ 3.533

Shareholders_ equity (deficie_5

Shareholders’ equity (deficiency) and redeemable convertible preferred shares - Schedule of Option Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Number of options [Roll Forward]
Outstanding at December 31, 2020 (in shares)	30,834,504	27,377,797
Options, grants in period (in shares)	70,678	9,909,539
Exercised (in shares)	2,626,573	693,101
Forfeited (in shares)	2,790,712	5,759,731
Outstanding at 31 December 2021 (in shares)	25,487,897	30,834,504	27,377,797
Exercisable at 31 December 2021 (in shares)	16,158,817	13,828,828
Weighted- average exercise price
Options outstanding, Weighted average exercise price per share - December 31 2020 (in USD per share)	$ 2.724	$ 3.033
Options granted, Weighted average exercise price per share (in USD per share)	5.036	2.215
Options exercised, Weighted average exercise price per share (in USD per share)	2.661	2.238
Options forfeited, Weighted average exercise price per share (in USD per share)	2.874	3.485
Options outstanding, Weighted average exercise price per share - December 31 2021 (in USD per share)	2.837	2.724	$ 3.033
Options exercisable, Weighted average exercise price per share (in USD per share)	$ 2.643	$ 2.618
Weighted- average remaining contractual term (in years)
Options outstanding, Weighted average remaining contractual term	7 years 10 days	8 years 1 month 20 days	8 years 7 months 2 days
Options exercisable, Weighted average remaining contractual term	6 years 5 months 12 days	5 years 8 months 12 days

Shareholders_ equity (deficie_6

Shareholders’ equity (deficiency) and redeemable convertible preferred shares - Schedule of RSU Activity (Details) - Restricted Stock Units (RSUs) - shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Outstanding at beginning of year (in shares)	893,629	1,898,810
Granted (in shares)	1,393,208	257,638
Vested (in shares)	178,254	805,716
Forfeited (in shares)	65,059	457,103
Outstanding at end of year (in shares)	2,043,524	893,629
2019 restricted share and restricted share units plan, deferral arrangements
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Vested (in shares)	43,356	229,156

Shareholders_ equity (deficie_7

Shareholders’ equity (deficiency) and redeemable convertible preferred shares - Schedule of Stock-based Compensation Cost (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based payment arrangement expense	$ 6,480	$ 7,271	$ 12,759
Cost of revenues
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based payment arrangement expense	290	304	190
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based payment arrangement expense	1,076	1,145	1,212
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based payment arrangement expense	2,332	2,298	2,969
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-based payment arrangement expense	$ 2,782	$ 3,524	$ 8,388

Net income (loss) per share (De

Net income (loss) per share (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Numerator:
Net income (loss)	$ 71,396	$ 5,781	$ (1,876)
Basic net income attributable to Preferred shareholders	0	(15,125)	(8,163)
Basic net income attributable to Restricted sponsor shares	(963)	0	0
Basic net income (loss) attributable to Ordinary shareholders	$ 70,433	$ (9,344)	$ (10,039)
Denominator:
Weighted average number of Ordinary shares used in computing basic net loss per share (in shares)	144,002,394	123,696,624	121,560,817
Basic net loss per share of Ordinary shareholders (in USD per share)	$ 0.49	$ (0.08)	$ (0.08)
Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in shares)	161,538,579	123,696,624	121,560,817
Diluted net income (loss) per share (in USD per share)	$ 0.44	$ (0.08)	$ (0.08)

Revenues (Details)

Revenues (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Disaggregation of Revenue [Line Items]
Total revenue	$ 246,246	$ 194,913	$ 171,854
Related party revenues	3,678	1,865	3,662
License and Service
Disaggregation of Revenue [Line Items]
Total revenue	183,317	129,745	86,647
Subscription services
Disaggregation of Revenue [Line Items]
Total revenue	120,889	100,614	81,505
Subscription services | Total revenues from subscription
Disaggregation of Revenue [Line Items]
Total revenue	120,889	100,614	81,505
Term-license
Disaggregation of Revenue [Line Items]
Total revenue	62,428	29,131	5,142
Term-license | Total revenues from subscription
Disaggregation of Revenue [Line Items]
Total revenue	62,428	29,131	5,142
Perpetual license and other
Disaggregation of Revenue [Line Items]
Total revenue	34,169	42,136	59,175
Professional services
Disaggregation of Revenue [Line Items]
Total revenue	$ 28,760	$ 23,032	$ 26,032

Cost of revenues (Details)

Cost of revenues (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cost of Revenues [Line Items]
Total cost of revenue	$ 42,557	$ 37,879	$ 35,823
Subscription services
Cost of Revenues [Line Items]
Total cost of revenue	9,369	8,795	6,585
Term-license
Cost of Revenues [Line Items]
Total cost of revenue	2,299	1,709	189
Perpetual license and other
Cost of Revenues [Line Items]
Total cost of revenue	9,817	9,370	10,049
Professional services
Cost of Revenues [Line Items]
Total cost of revenue	21,072	18,005	19,000
Materials and changes in inventories
Cost of Revenues [Line Items]
Total cost of revenue	10,316	10,532	7,638
Payroll and related expenses
Cost of Revenues [Line Items]
Total cost of revenue	19,754	17,019	14,272
Training expenses
Cost of Revenues [Line Items]
Total cost of revenue	3,885	2,713	5,338
Shipping expenses
Cost of Revenues [Line Items]
Total cost of revenue	1,548	1,543	1,784
Depreciation and Amortization
Cost of Revenues [Line Items]
Total cost of revenue	1,080	1,327	1,501
Inventory write-off
Cost of Revenues [Line Items]
Total cost of revenue	230	150	262
Travel
Cost of Revenues [Line Items]
Total cost of revenue	1,410	866	1,561
Other
Cost of Revenues [Line Items]
Total cost of revenue	$ 4,334	$ 3,729	$ 3,467

Sales and marketing (Details)

Sales and marketing (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of Other Operating Income and Expense [Line Items]
Sales and marketing	$ 76,389	$ 61,305	$ 61,610
Payroll and related expenses
Schedule of Other Operating Income and Expense [Line Items]
Sales and marketing	48,901	39,991	36,559
Sales commissions
Schedule of Other Operating Income and Expense [Line Items]
Sales and marketing	10,312	8,246	6,624
Marketing and advertising
Schedule of Other Operating Income and Expense [Line Items]
Sales and marketing	5,274	4,098	5,322
Travel and entertainment
Schedule of Other Operating Income and Expense [Line Items]
Sales and marketing	2,279	1,276	4,939
Rent and maintenance
Schedule of Other Operating Income and Expense [Line Items]
Sales and marketing	2,513	2,640	2,661
Depreciation and amortization
Schedule of Other Operating Income and Expense [Line Items]
Sales and marketing	1,872	1,877	824
Vehicle costs
Schedule of Other Operating Income and Expense [Line Items]
Sales and marketing	466	423	448
Professional consultants
Schedule of Other Operating Income and Expense [Line Items]
Sales and marketing	1,349	808	1,889
Recruiting expenses
Schedule of Other Operating Income and Expense [Line Items]
Sales and marketing	1,043	330	859
Other
Schedule of Other Operating Income and Expense [Line Items]
Sales and marketing	$ 2,380	$ 1,616	$ 1,485

Research and development (Detai

Research and development (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of Other Operating Income and Expense [Line Items]
Research and development	$ 65,541	$ 54,377	$ 46,573
Payroll and related expenses
Schedule of Other Operating Income and Expense [Line Items]
Research and development	53,683	45,716	39,142
Rent and maintenance
Schedule of Other Operating Income and Expense [Line Items]
Research and development	1,851	2,117	1,721
Subcontractors And Projects Expense [Member]
Schedule of Other Operating Income and Expense [Line Items]
Research and development	3,482	2,676	2,398
Travel and entertainment
Schedule of Other Operating Income and Expense [Line Items]
Research and development	185	20	314
Vehicle costs
Schedule of Other Operating Income and Expense [Line Items]
Research and development	232	270	355
Recruiting expenses
Schedule of Other Operating Income and Expense [Line Items]
Research and development	178	127	222
Depreciation and amortization
Schedule of Other Operating Income and Expense [Line Items]
Research and development	2,100	1,813	1,135
Other
Schedule of Other Operating Income and Expense [Line Items]
Research and development	$ 3,830	$ 1,638	$ 1,286

General and administrative (Det

General and administrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Schedule of Other Operating Income and Expense [Line Items]
General and administrative	$ 47,937	$ 32,134	$ 29,368
Payroll and related expenses
Schedule of Other Operating Income and Expense [Line Items]
General and administrative	19,366	18,460	16,386
Professional fees
Schedule of Other Operating Income and Expense [Line Items]
General and administrative	4,307	4,274	2,040
Vehicle costs
Schedule of Other Operating Income and Expense [Line Items]
General and administrative	469	328	263
Rent and maintenance
Schedule of Other Operating Income and Expense [Line Items]
General and administrative	1,559	2,147	2,071
Travel and entertainment
Schedule of Other Operating Income and Expense [Line Items]
General and administrative	249	262	425
Refreshments, gifts and donations
Schedule of Other Operating Income and Expense [Line Items]
General and administrative	525	778	645
Doubtful accounts and bad debts
Schedule of Other Operating Income and Expense [Line Items]
General and administrative	676	606	266
Recruiting expenses
Schedule of Other Operating Income and Expense [Line Items]
General and administrative	727	330	386
Depreciation
Schedule of Other Operating Income and Expense [Line Items]
General and administrative	1,955	978	484
Issuance costs
Schedule of Other Operating Income and Expense [Line Items]
General and administrative	11,835	0	0
Other
Schedule of Other Operating Income and Expense [Line Items]
General and administrative	$ 6,269	$ 3,971	$ 6,402

Financial income, net (Details)

Financial income, net (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Financial income:
Interest on deposits	$ 847	$ 2,710	$ 3,475
Foreign currency translation differences	51	780	380
Revaluation of liability instruments	67,873	0	0
Other	276	112	0
Financial expenses:
Bank charges	(166)	(197)	(222)
Changes in exchange rates	(245)	(1,226)	(568)
Other	(153)	0	(130)
Financial income, net	$ 68,483	$ 2,179	$ 2,935

Dividend distribution (Details)

Dividend distribution (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Dividends [Abstract]
Dividend paid	$ 100,000	$ 10,000	$ 25,000

Transactions and Balances_wit_3

Transactions and Balances with Related Parties (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Related Party Transactions [Abstract]
Revenues	$ 3,678	$ 1,865	$ 3,662
Trade receivables	214	0
Trade payables	$ 0	$ (154)

Taxes on income - Narrative (De

Taxes on income - Narrative (Details) - USD ($) $ in Thousands	Aug. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Investments, Owned, Federal Income Tax Note [Line Items]
Decrease in provision for tax on trapped earnings due to utilization in period	$ 71	$ 71
Increase in provision for tax on trapped earnings due to additional provision recognized		7
Undistributed earnings of foreign subsidiaries		25,768
Deferred tax liability not recognized, undistributed earnings of foreign subsidiaries		4,125
Interest on income taxes accrued		168	$ 76
Unrecognized Tax Benefits, Interest on Income Taxes Expense		$ 92	$ 25	$ 51
Approved Enterprise and Beneficiary Enterprise | Minimum
Investments, Owned, Federal Income Tax Note [Line Items]
Beneficial tax rate		0.00%
Approved Enterprise and Beneficiary Enterprise | Maximum
Investments, Owned, Federal Income Tax Note [Line Items]
Beneficial tax rate		10.00%

Taxes on income - Significant C

Taxes on income - Significant Components of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2021	Dec. 31, 2020
Deferred tax assets:
Deferred research and development cost	$ 3,556	$ 4,970
Employee related liabilities	842	906
Intangible assets	1,125	1,304
Goodwill	2,773	1,354
Deferred revenues	1,765	1,164
Issuance costs	1,347	0
Other	1,068	431
Total deferred tax assets	12,476	10,129
Deferred tax liabilities:
Deferred costs	1,324	1,242
Intangible assets	545	771
Goodwill	180	68
Property and equipment	438	455
Derivative instruments	79	208
Other	110	13
Total deferred tax liabilities	2,676	2,757
Total deferred tax assets, net	$ 9,800	$ 7,372

Taxes on income - Schedule of I

Taxes on income - Schedule of Income Tax Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Income before income taxes expense, as reported in the consolidated statements of operations	$ 82,305	$ 11,397	$ 1,415
Statutory tax rate in Israel	23.00%	23.00%	23.00%
Theoretical taxes on income	$ 18,930	$ 2,621	$ 325
Foreign subsidiaries taxed at different tax rates	167	81	76
Preferred tax rates in Israel	(7,598)	(72)	937
Revaluation of liability instruments	(8,145)	0	0
Non-deductible expense	1,363	1,501	2,293
Taxes in respect of prior years	(125)	78	(283)
Intercompany transfer of intangible assets	0	1,324	0
Tax on dividend distributed from trapped earnings	7,068	0	0
Other	(751)	83	(57)
Income tax expense	$ 10,909	$ 5,616	$ 3,291

Taxes on income - Schedule of_2

Taxes on income - Schedule of Income Before Tax (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Domestic	$ 71,434	$ 4,348	$ (3,920)
Foreign	10,871	7,049	5,335
Income before income tax expense	$ 82,305	$ 11,397	$ 1,415

Taxes on income - Schedule of_3

Taxes on income - Schedule of Income Tax Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Current:
Israel	$ 9,665	$ 4,549	$ 3,950
Foreign	2,882	3,885	1,008
Total current tax expense:	12,547	8,434	4,958
Deferred:
Israel	(10)	(3,729)	(1,897)
Foreign	(1,628)	911	230
Total deferred tax benefit	(1,638)	(2,818)	(1,667)
Income tax expense	$ 10,909	$ 5,616	$ 3,291

Taxes on income - Schedule of U

Taxes on income - Schedule of Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Unrecognized tax benefits, beginning of year	$ 2,007	$ 1,689
Decreases in tax positions for prior years	0	(388)
Increases in tax positions for current year	1,231	706
Unrecognized tax benefits, end of year	$ 3,238	$ 2,007